Perforation of tympanic membrane

H8_PERFORATION

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H72 Hospital discharge: ICD-9 — 3842 Cause of death: ICD-10 — H72 Cause of death: ICD-9 — 3842 2 out of 7 registries used, show all original rules.	4773
4. Check minimum number of events None	4773
5. Include endpoints None	4773
6. Filter based on genotype QC (FinnGen only)	4232

Control definitions (FinnGen only)

Control exclude: H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H65-H75
Name in latin: Perforatio membranae tympanicae

NAME	H8_PERFORATION
CONTROL_EXCLUDE	H8_MIDDLEMASTOID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H72
HD_ICD_9	3842
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H72
COD_ICD_9	3842
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Perforation of tympanic membrane based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	39492	18838	20408
Only index persons	35816	17317	18499
Unadjusted period prevalence (%)
Whole population	0.55	0.54	0.57
Only index persons	0.67	0.64	0.71
Median age at first event (years)
Whole population	38.96	43.48	34.79
Only index persons	39.96	44.51	35.70

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4232	2369	1863
Unadjusted period prevalence (%)	0.85	0.84	0.85
Median age at first event (years)	52.65	50.45	55.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4470: Matched controls
44700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TDA90

NOMESCO Finland

Removal wax from ear

17.6

314.7

260

156

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

183.8

307.7

371

H71

ICD-10 Finland

Cholesteatoma of middle ear

4647.8

307.7

432

H72

ICD-10 Finland

Perforation of tympanic membrane

174.4

307.7

184

H60.9

ICD-10 Finland

Otitis externa, unspecified

5.9

307.7

892

1824

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

197.6

307.7

875

DCD00

NOMESCO Finland

Myringoplasty

14803.0

307.7

1126

Z01.1

ICD-10 Finland

Examination of ears and hearing

6.7

307.7

1638

3560

H65.3

ICD-10 Finland

Chronic mucoid otitis media

281.0

307.7

749

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

6343.5

307.7

3386

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

39.0

307.7

205

3842A

ICD-9 Finland

Other disorders of tympanic membrane, Perforation of tympanic membrane

+∞

307.7

431

DC1AD

NOMESCO Finland

Temporalbone CT

56.7

307.7

389

4141

FHL

Myringoplasty (also for reasons other than inflammation)

1057.4

307.7

387

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

21.2

307.7

413

214

H65.0

ICD-10 Finland

Acute serous otitis media

20.5

307.7

319

167

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

51.3

307.7

402

DFF00

NOMESCO Finland

Pure tone audiometry

7.1

307.7

1275

2364

4122

FHL

Tympanostomy (tympanic tube)

107.8

307.7

235

UDC00

NOMESCO Finland

Ear microscopy

15.6

307.7

1494

1391

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

985.7

307.7

599

H66.9

ICD-10 Finland

Otitis media, unspecified

10.6

307.7

979

1152

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

60.9

307.7

296

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

172.9

307.7

291

H66.0

ICD-10 Finland

Acute suppurative otitis media

16.5

307.7

1442

1256

H65.2

ICD-10 Finland

Chronic serous otitis media

234.1

307.7

424

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

346.8

307.7

702

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

15.8

304.4

266

178

H60.3

ICD-10 Finland

Other infective otitis externa

9.8

285.6

342

375

H04

ICPC

Ear discharge

7.4

280.7

429

632

H60.8

ICD-10 Finland

Other otitis externa

7.8

266.0

386

536

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

15.2

262.5

234

162

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

37.8

254.0

157

H01

ICPC

Ear pain/earache

3.5

231.7

944

3137

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

14.8

228.8

206

145

S09.2

ICD-10 Finland

Traumatic rupture of ear drum

37.6

218.2

135

H66

ICD-10 Finland

Suppurative and unspecified otitis media

7.8

217.5

313

429

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

+∞

210.1

200

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

3.0

207.6

1144

4532

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

202.0

2832

17802

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

45.8

196.9

116

H72.1

ICD-10 Finland

Attic perforation of tympanic membrane

338.2

195.1

196

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.6

193.8

1637

8062

DCD10

NOMESCO Finland

Tympanoplasty

471.7

183.5

182

H74.1

ICD-10 Finland

Adhesive middle ear disease

925.4

182.7

178

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

+∞

182.6

174

H92.1

ICD-10 Finland

Otorrhoea

53.8

175.6

100

S02CA02

ATC

flumetasone and antiinfectives; otic

4.6

173.6

438

1023

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

6.0

171.4

316

560

DCA40

NOMESCO Finland

Fat patching or other similar technique without opening of tympanic membrane

+∞

159.3

152

EMB30

NOMESCO Finland

Adenotomy

8.7

158.3

204

244

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

795.8

157.4

154

H29

ICPC

Ear symptom/complaint other

3.0

154.3

832

3207

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

7.2

153.8

234

340

H70.1

ICD-10 Finland

Chronic mastoiditis

+∞

151.9

145

DFF15

NOMESCO Finland

Speech audiometry

4.4

147.6

400

985

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.4

146.7

392

955

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

3.7

139.4

483

1418

H60

ICD-10 Finland

Otitis externa

4.0

137.7

423

1142

DGW00

NOMESCO Finland

Dilatation of eustachian tube

+∞

136.1

130

H92.0

ICD-10 Finland

Otalgia

3.6

135.8

482

1437

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

+∞

133.0

127

H61.2

ICD-10 Finland

Impacted cerumen

3.5

129.3

498

1564

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

12.1

123.9

125

106

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

216.0

122.3

126

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

120.5

454

1404

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.8

120.2

392

1101

DAX08

NOMESCO Finland

Fitting of hearing aid

3.6

117.3

416

1236

H73.1

ICD-10 Finland

Chronic myringitis

1137.0

114.1

111

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

+∞

110.9

106

H60.4

ICD-10 Finland

Cholesteatoma of external ear

26.5

106.0

4451

FHL

Guitar cutting

5.9

104.7

194

344

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

140.9

103.5

110

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

+∞

99.3

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.0

91.8

269

698

J01CA04

ATC

amoxicillin; systemic

2.4

91.5

3827

31897

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

+∞

90.9

H73.0

ICD-10 Finland

Acute myringitis

16.3

90.8

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

13.5

90.5

DEA10

NOMESCO Finland

Attico-antrotomy

854.6

85.9

H71

ICPC

Acute otitis media/myringitis

7.2

82.6

124

177

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.9

81.3

252

680

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

78.6

474

1900

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

+∞

78.4

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

+∞

78.4

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

+∞

78.4

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

8.2

75.5

101

126

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

+∞

75.2

R01AD08

ATC

fluticasone; nasal

1.9

72.7

1342

8356

J01DB01

ATC

cefalexin; oral

2.1

70.8

3741

31792

H69.0

ICD-10 Finland

Patulous Eustachian tube

17.5

69.6

1450

FHL

Otomicroscopy

16.3

68.5

J01DA01

ATC

[U] cefalexin

1.7

67.9

2710

20960

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

+∞

67.9

J01MA02

ATC

ciprofloxacin; systemic

1.7

66.6

1744

11982

J01DC02

ATC

cefuroxime; systemic

3.0

66.2

312

1094

R01AD09

ATC

mometasone; nasal

1.7

64.6

2043

14749

H02

ICPC

Hearing complaint

2.1

63.7

728

3829

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

3.3

62.7

242

754

H70

ICPC

Otitis externa

4.3

60.1

157

373

H77

ICPC

Perforation ear drum

94.3

59.0

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

+∞

58.5

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

+∞

58.5

H02AB06

ATC

prednisolone; systemic

1.6

55.3

2076

15456

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

3.8

55.1

169

452

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

53.0

390

1708

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

+∞

52.2

R5120

NOMESCO Finland

Preparation of an aid

3.5

52.1

186

551

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

50.9

1141

7392

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.4

50.1

183

550

J01FA10

ATC

azithromycin; systemic

1.6

49.4

2503

19827

J01DA08

ATC

[U] cefaclor

2.1

48.7

538

2776

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.7

48.3

282

1105

ZXA10

NOMESCO Finland

Bilateral

1.8

46.8

812

4868

H02AB04

ATC

methylprednisolone; systemic

1.9

46.2

631

3505

H13

ICPC

Plugged feeling ear

1.8

45.3

887

5505

J35.2

ICD-10 Finland

Hypertrophy of adenoids

4.4

43.3

110

256

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

+∞

42.8

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

2.2

42.7

407

1982

J01DA06

ATC

[U] cefuroxime

1.9

42.5

623

3536

H69.8

ICD-10 Finland

Other specified disorders of Eustachian tube

11.1

42.4

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

211.9

40.9

J01FA09

ATC

clarithromycin; systemic

1.6

40.4

1303

9168

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

40.1

571

3205

R4135

NOMESCO Finland

Rehabilitation for hearing problems

4.0

40.1

114

289

J01FF01

ATC

clindamycin; systemic

1.6

39.9

1140

7787

DEB30

NOMESCO Finland

Radical mastoidectomy

206.8

39.9

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

+∞

39.6

ZXA05

NOMESCO Finland

Left side

1.7

39.5

1012

6725

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

39.0

1187

8226

SPAT1043

SPAT

Audiometry

2.0

38.9

464

2452

J01DA09

ATC

[U] cefadroxil

1.6

37.3

1088

7449

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

+∞

36.5

ZXD20

NOMESCO Finland

Day surgery

1.8

36.3

557

3198

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

35.5

3126

26957

J33.8

ICD-10 Finland

Other polyp of sinus

3.6

35.5

118

334

ZZF00

NOMESCO Finland

Graft of adipose tissue

5.9

34.7

106

H73.8

ICD-10 Finland

Other specified disorders of tympanic membrane

93.3

33.7

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

33.7

812

5287

UDM02

NOMESCO Finland

Sinoscopy

3.4

33.6

120

356

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

+∞

33.4

S02AA03

ATC

boric acid; otic

5.7

33.0

108

DCW00

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

329.6

32.9

4121

FHL

Tympanic puncture or parasentosis in general anesthesia or operating room

6.5

32.8

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

171.3

32.7

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.4

32.7

244

1071

4144

FHL

Mastoidectomy or aticomastoidectomy

+∞

32.3

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

62.2

32.0

ZXA00

NOMESCO Finland

Right side

1.6

32.0

1047

7326

R01AD12

ATC

fluticasone furoate; nasal

1.5

31.9

1316

9679

H61.8

ICD-10 Finland

Other specified disorders of external ear

4.9

31.8

145

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.1

31.3

135

449

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

30.8

1044

7353

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

30.6

468

2678

J32.4

ICD-10 Finland

Chronic pansinusitis

3.9

30.5

230

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

30.3

154

562

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

30.1

1952

15633

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

30.0

260

1215

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

30.0

955

6625

UDC10

NOMESCO Finland

Tympanoscopy

68.4

29.9

M31.3

ICD-10 Finland

Wegener granulomatosis

10.4

29.8

N02BE01

ATC

paracetamol; systemic, rectal

1.7

29.5

3843

35182

SPAT1301

SPAT

No procedures

1.5

29.3

1300

9671

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

7.7

29.3

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.8

29.0

144

519

R03AC02

ATC

salbutamol; inhalant

1.4

28.5

2282

18919

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

3.8

28.4

224

38400

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta

+∞

28.1

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

28.0

140

506

H70.0

ICD-10 Finland

Acute mastoiditis

283.3

27.8

J01DC04

ATC

cefaclor; oral

4.2

27.8

179

4150

FHL

Tympanoplasty (including for reasons other than inflammation)

100.7

27.7

74900

ICD-8 Finland

Cleft palate and cleft lip, Cleft palate

100.7

27.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

27.6

1165

8559

A02BC02

ATC

pantoprazole; systemic

1.4

27.4

2820

24361

DCA30

NOMESCO Finland

Exploration of middle ear

53.7

27.2

4222

FHL

Endonasal etmoidectomy

6.2

27.0

SPAT1263

SPAT

Sampling

1.4

27.0

1739

13825

H60.1

ICD-10 Finland

Cellulitis of external ear

4.0

26.7

193

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

26.7

731

4886

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

5.9

26.5

SPAT1044

SPAT

Tympanometry

3.1

26.4

110

359

J01AA02

ATC

doxycycline; systemic

1.4

25.8

3153

27919

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

25.7

1038

7545

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

25.5

308

1629

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

24.7

774

5324

N02AX02

ATC

tramadol; systemic, rectal

1.4

24.7

1682

13440

Q35.1

ICD-10 Finland

Cleft hard palate

43.1

24.5

H65

ICD-10 Finland

Nonsuppurative otitis media

4.2

24.3

158

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

8.9

24.2

DEB00

NOMESCO Finland

Cortical mastoidectomy

87.2

23.7

4741B

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]

4.2

23.6

153

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

22.9

778

5441

S18

ICPC

Laceration/cut

1.4

22.7

1919

15825

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

22.7

172

761

1451

FHL

Otomicroscopy and paper place

231.1

22.6

H95.8

ICD-10 Finland

Other postprocedural disorders of ear and mastoid process

120.6

22.6

ZZG00

NOMESCO Finland

Graft of cartilage

19.0

22.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

22.5

1446

11395

SPAT1260

SPAT

Consultation of another employee

1.5

22.5

703

4827

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

22.5

230

1147

R42

ICD-10 Finland

Dizziness and giddiness

1.5

22.4

923

6708

ZXC10

NOMESCO Finland

Use of laser

2.9

22.3

104

363

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

22.2

1500

11915

R03BA05

ATC

fluticasone; inhalant

1.5

22.1

718

4968

R01AD58

ATC

fluticasone, combinations; nasal

1.4

22.0

1009

7485

R03DC03

ATC

montelukast; oral

1.6

21.9

650

4409

DCB00

NOMESCO Finland

Excision of lesion of middle ear

221.0

21.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

21.6

1366

10723

R01AD11

ATC

triamcinolone; nasal

1.8

21.1

342

1986

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

21.1

1270

9879

WX400

NOMESCO Finland

Inhalation anesthesy

2.2

21.0

177

818

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.8

20.8

163

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.6

20.8

186

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

4.2

20.7

133

SPAT1153

SPAT

Removal of sutures

1.4

20.6

1205

9318

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

20.2

872

6379

J02AC01

ATC

fluconazole; systemic

1.4

20.2

1475

11819

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

20.2

1703

13956

SFA10

NOMESCO Finland

One-surface restoration

1.3

20.2

2269

19415

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

20.1

561

3748

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

19.9

536

3550

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

19.9

423

2646

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

105.5

19.6

H74.0

ICD-10 Finland

Tympanosclerosis

200.9

19.6

N07CA01

ATC

betahistine; oral

1.8

19.5

279

1559

Z97.8

ICD-10 Finland

Presence of other specified devices

6.0

19.5

J01MA12

ATC

levofloxacin; systemic

1.5

19.4

693

4883

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

19.2

1352

10752

K02.1

ICD-10 Finland

Caries of dentine

1.3

19.2

2444

21232

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

19.1

1697

13984

R02

ICPC

Shortness of breath/dyspnoea

1.6

19.1

551

3709

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

19.0

357

2161

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

4.4

18.9

108

DDD05

NOMESCO Finland

Plastic repair of ossicular chain

70.2

18.7

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.9

18.5

305

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

18.4

1173

9169

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

18.3

2995

26890

H27

ICPC

Fear of ear disease

3.4

18.3

198

H60.0

ICD-10 Finland

Abscess of external ear

5.0

18.3

38798

ICD-8 Finland

Other disease of ear and mastoid process, Alii definiti

13.6

18.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

18.2

471

3091

R01AD05

ATC

budesonide; nasal

1.8

18.2

289

1668

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

6.1

18.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

18.1

414

2637

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

18.0

728

5248

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

18.0

1830

15341

T16

ICD-10 Finland

Foreign body in ear

3.8

17.9

148

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.2

17.9

226

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

17.9

2061

17583

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

17.7

2191

18865

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

17.7

214

1133

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

17.6

234

1277

A02BC01

ATC

omeprazole; systemic

1.4

17.6

1028

7915

SPAT1310

SPAT

Counselling related to known health issue

1.4

17.6

1246

9894

7490A

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]

95.4

17.6

H62.2*B44.8

ICD-10 Finland

Otitis externa in aspergillosis

95.4

17.6

H74.4

ICD-10 Finland

Polyp of middle ear

180.7

17.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

17.5

534

3634

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

4.7

17.5

R06AE07

ATC

cetirizine; oral

1.3

17.4

1737

14501

J47

ICD-10 Finland

Bronchiectasis

2.9

17.1

291

ZXE00

NOMESCO Finland

One hour or less

1.3

17.1

1471

12014

SPAT1312

SPAT

General health counselling

1.4

17.1

1266

10113

H80.9

ICD-10 Finland

Otosclerosis, unspecified

3.9

17.0

126

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

17.0

755

5537

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

16.9

461

3058

A02BC03

ATC

lansoprazole; oral

1.4

16.8

1038

8055

ZYC03

NOMESCO Finland

Remote contact, text-based

4.7

16.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.7

1195

9486

WX704

NOMESCO Finland

Intubation

1.7

16.7

323

1970

P01AB01

ATC

metronidazole; oral, rectal

1.3

16.6

1509

12412

DCB10

NOMESCO Finland

Freeing of adhesions of middle ear

90.4

16.6

DEB35

NOMESCO Finland

Radical mastoidectomy with tympanoplasty

170.6

16.5

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

16.4

2803

25097

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

16.4

275

1612

R51.80

ICD-10 Finland

Headache

1.5

16.4

627

4468

R06.0

ICD-10 Finland

Dyspnoea

1.4

16.2

1047

8175

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

16.2

349

2189

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

16.2

173

878

H92.2

ICD-10 Finland

Otorrhagia

6.8

16.1

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

15.9

207

1122

SPAT1254

SPAT

Administration of medicine

1.5

15.9

596

4229

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

12.2

15.8

DCA00

NOMESCO Finland

Biopsy of tympanic membrane or middle ear

60.2

15.8

J01CA02

ATC

pivampicillin; oral

2.3

15.7

122

547

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

15.6

1133

9001

R74

ICPC

Upper respiratory infection acute

1.3

15.6

1328

10801

H91.8

ICD-10 Finland

Other specified hearing loss

3.3

15.6

173

X58

ICD-10 Finland

Exposure to other specified factors

1.5

15.6

579

4101

A03

ICPC

Fever

1.4

15.3

710

5240

H90

ICD-10 Finland

Conductive and sensorineural hearing loss

5.9

15.2

H69.9

ICD-10 Finland

Eustachian tube disorder, unspecified

5.9

15.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

15.2

514

3571

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

15.1

2743

24615

N05AH04

ATC

quetiapine; oral

1.4

15.1

683

5017

H73.9

ICD-10 Finland

Disorder of tympanic membrane, unspecified

23.4

15.1

WX402

NOMESCO Finland

General anaesthesia

1.4

15.0

859

6568

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

3.7

14.8

125

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

14.8

934

7255

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

14.7

484

3343

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

18.4

14.7

L08

ICPC

Shoulder symptom/complaint

1.4

14.7

879

6769

H81.3

ICD-10 Finland

Other peripheral vertigo

2.3

14.6

115

518

Q37.1

ICD-10 Finland

Cleft hard palate with unilateral cleft lip

21.1

14.6

4143

FHL

Atticotomy or atticoanthromy through the ear canal

+∞

14.6

H70.9

ICD-10 Finland

Mastoiditis, unspecified

+∞

14.6

3824A

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified suppurative otitis media

+∞

14.6

DFF59

NOMESCO Finland

Other assessment of balance

3.4

14.5

151

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

14.5

377

2474

4147

FHL

Radical surgery, cavity filling and middle ear and / or eardrum plastic

150.5

14.5

H02AB07

ATC

prednisone; oral

1.5

14.4

480

3324

SFA20

NOMESCO Finland

Two-surface restoration

1.3

14.4

2321

20461

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

14.3

1674

14174

A02BC05

ATC

esomeprazole; systemic

1.3

14.2

1506

12582

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

14.2

919

7159

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

14.2

1048

8328

EBA00

NOMESCO Finland

Extraction of tooth

1.3

14.2

1472

12264

EMB10

NOMESCO Finland

Tonsillectomy

1.8

14.2

217

1239

S29

ICPC

Skin symptom/complaint other

1.4

14.1

803

6132

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.8

14.0

249

DDA00

NOMESCO Finland

Stapedotomy

3.9

14.0

107

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

14.0

738

5560

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

13.9

480

3344

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.9

1482

12381

J20

ICD-10 Finland

Acute bronchitis

1.5

13.9

387

2579

RK520, ,

NOMESCO Finland

6.0

13.8

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

13.8

390

2605

N03AX16

ATC

[U] pregabalin

1.4

13.8

826

6355

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

13.7

495

3482

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

13.7

228

1334

A07AA02

ATC

nystatin; oral

1.8

13.6

211

1209

4226

FHL

Posterior radical surgery and possible etmoidectomy

3.8

13.6

105

4224

FHL

Endonasal anthrostomy

3.5

13.6

133

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

3.6

13.5

119

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.9

13.5

221

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

13.5

922

7235

R96

ICPC

Asthma

1.5

13.5

381

2546

4151

FHL

Reoperation for chronic otitis media

140.4

13.4

D07AC01

ATC

betamethasone; topical

1.3

13.4

1381

11475

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

13.4

1175

9556

SAA04

NOMESCO Finland

Special examination of mouth

1.8

13.3

212

1224

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

4.9

13.1

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.3

13.1

100

446

R03BB04

ATC

tiotropium bromide; inhalant

1.6

13.1

352

2327

J46

ICD-10 Finland

Status asthmaticus

2.2

12.9

110

513

AA1AD

NOMESCO Finland

CT of head and brain

1.3

12.9

1066

8594

WX002

NOMESCO Finland

Sedation and analgesia

1.4

12.8

690

5210

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

12.8

162

872

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

5.8

12.7

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

12.7

431

2994

J01FA06

ATC

roxithromycin; oral

1.3

12.6

1444

12137

H61.9

ICD-10 Finland

Disorder of external ear, unspecified

4.9

12.6

4362

FHL

Nozzle reconstruction

70.1

12.6

J01MA14

ATC

moxifloxacin; systemic

1.6

12.5

317

2066

Q90.9

ICD-10 Finland

Down syndrome, unspecified

+∞

12.5

3811A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media

+∞

12.5

M79.6

ICD-10 Finland

Pain in limb

1.3

12.5

1702

14613

R03BA02

ATC

budesonide; inhalant

1.4

12.4

651

4892

H93.1

ICD-10 Finland

Tinnitus

1.7

12.4

256

1587

SFA30

NOMESCO Finland

Three-surface restoration

1.3

12.4

1572

13376

E0000UV, ,

ATC

1.3

12.3

1636

13996

R06AX27

ATC

desloratadine; oral

1.3

12.3

1095

8906

SPAT1325

SPAT

Vaccination

1.3

12.3

1262

10457

WX290

NOMESCO Finland

Other blockage of nerve

1.3

12.2

1881

16364

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.9

12.2

141

736

4129

FHL

Other measure in this category

37.6

12.2

L17

ICPC

Foot/toe symptom/complaint

1.3

12.2

1183

9729

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

12.1

242

1489

DC1BD

NOMESCO Finland

Temporal bone extensive CT

26.7

12.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

12.0

716

5495

N06AX11

ATC

mirtazapine; oral

1.3

12.0

1293

10775

N06AX16

ATC

venlafaxine; oral

1.4

11.9

524

3819

J45

ICD-10 Finland

Asthma

1.5

11.9

383

2630

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

11.9

1178

9707

L15

ICPC

Knee symptom/complaint

1.3

11.9

957

7671

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

11.9

102

478

UKC02

NOMESCO Finland

Cystoscopy

1.4

11.9

555

4091

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

30.1

11.6

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

11.6

314

2078

H74.3

ICD-10 Finland

Other acquired abnormalities of ear ossicles

65.1

11.6

SPAT1360

SPAT

Extensive global examination

1.6

11.6

245

1529

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

11.6

660

5025

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

11.6

582

4342

S02

ICPC

Pruritus

1.9

11.5

149

809

L12

ICPC

Hand/finger symptom/complaint

1.4

11.5

669

5112

H05

ICPC

Bleeding ear

4.3

11.5

WX720

NOMESCO Finland

Own respiration

1.8

11.4

185

1075

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.4

1210

10051

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.8

11.4

192

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

11.3

1034

8424

R03AC03

ATC

terbutaline; inhalant

1.4

11.3

485

3519

N07BB01

ATC

disulfiram; oral

1.9

11.2

149

815

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

11.2

921

7397

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.2

1534

13129

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.2

1543

13217

A02BA02

ATC

ranitidine; systemic

1.4

11.2

649

4955

N05CF01

ATC

zopiclone; oral

1.3

11.0

1154

9563

R03AC12

ATC

salmeterol; inhalant

1.8

11.0

150

828

H83.0

ICD-10 Finland

Labyrinthitis

10.0

11.0

L28

ICPC

Limited function/disability (L)

1.3

10.8

687

5314

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

10.8

585

4414

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

10.7

162

924

RK110, ,

NOMESCO Finland

3.7

10.7

T90

ICPC

Diabetes non-insulin dependent

1.3

10.6

849

6787

DC1AA

NOMESCO Finland

Temporalbone X-ray examination

60.1

10.6

M54.5

ICD-10 Finland

Low back pain

1.3

10.6

1386

11782

Z01.2

ICD-10 Finland

Dental examination

1.2

10.5

1845

16197

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

10.5

936

7590

R05

ICPC

Cough

1.3

10.5

953

7748

SPAT1229

SPAT

Assessment of need for aid

1.6

10.5

262

1703

DDD20

NOMESCO Finland

Interposition between eardrum and footplate of stapes

+∞

10.4

7490B

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]

+∞

10.4

R4110, ,

SPAT

1.4

10.4

480

3527

D11

ICPC

Diarrhoea

1.4

10.4

462

3374

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

10.3

237

1510

SBB10

NOMESCO Finland

Dental impressions

1.5

10.3

275

1814

DBW99

NOMESCO Finland

Other operation on external auditory canal

32.6

10.3

8726A

ICD-9 Finland

Open wound of ear, Other specified parts of ear, without mention of complication[VULNUS MEMBRANAE TYMPANI, NON COMPLICATUM]

32.6

10.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

10.3

357

2488

Z71.8

ICD-10 Finland

Other specified counselling

1.3

10.3

1321

11198

SPAT1172

SPAT

Guidance concerning hydration

2.2

10.2

375

C03CA01

ATC

furosemide; systemic

1.3

10.1

1041

8593

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

10.1

788

6276

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

10.1

533

4006

R01AD01

ATC

beclometasone; nasal

1.4

10.0

522

3916

Q35.9

ICD-10 Finland

Cleft palate, unspecified

40.1

10.0

DPA30

NOMESCO Finland

Sphenotomy

3.7

10.0

R06AX13

ATC

loratadine; oral

1.4

9.9

524

3937

R03AC13

ATC

formoterol; inhalant

1.7

9.9

165

967

H81.0

ICD-10 Finland

Ménière disease

2.1

9.8

420

H74

ICPC

Chronic otitis media

26.1

9.8

DC1AI

NOMESCO Finland

Cone beam CT of ear

20.1

9.8

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

9.8

221

1404

T82

ICPC

Obesity

1.8

9.7

149

853

H28

ICPC

Limited function/disability (H)

2.8

9.6

170

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

9.6

480

3573

P76

ICPC

Depressive disorder

1.6

9.6

252

1657

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

9.6

449

3306

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

9.6

142

805

G44.2

ICD-10 Finland

Tension-type headache

1.4

9.6

491

3672

RK420, ,

NOMESCO Finland

11.4

9.5

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.1

9.5

452

N05BA04

ATC

oxazepam; oral

1.3

9.5

952

7823

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

9.5

870

7071

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

9.5

386

2774

B01AB05

ATC

enoxaparin; parenteral

1.3

9.5

1114

9333

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

100.3

9.4

3851A

ICD-9 Finland

Other disorders of middle ear and mastoid, Adhesive middle ear disease

+∞

9.4

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

9.4

395

J01MA01

ATC

ofloxacin; systemic

1.5

9.4

267

1789

S02CA03

ATC

hydrocortisone and antiinfectives; otic

12.3

9.3

A06AD11

ATC

lactulose; oral

1.4

9.3

502

3783

L04AX01

ATC

azathioprine; systemic

1.8

9.3

147

850

S01AA01

ATC

chloramphenicol; ophthalmic

1.7

9.3

172

1039

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

9.3

252

1671

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

9.3

218

1399

G47.3

ICD-10 Finland

Sleep apnoea

1.3

9.2

795

6408

R52.9

ICD-10 Finland

Pain, unspecified

1.4

9.2

372

2669

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

9.2

372

2669

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

9.2

831

6742

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

9.1

229

1491

ZXD05

NOMESCO Finland

Urgent procedure

1.3

9.1

1078

9034

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

9.1

371

2668

K11.2

ICD-10 Finland

Sialoadenitis

1.9

9.1

117

636

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

9.0

340

2409

L03

ICPC

Low back symptom/complaint

1.3

9.0

1109

9334

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

9.0

337

2387

M03BX02

ATC

tizanidine; oral

1.2

9.0

2321

21071

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

8.9

583

4523

74920

ICD-8 Finland

Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis

18.6

8.9

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

24.0

8.9

4364

FHL

Pharyngeal tongue plastic

24.0

8.9

7492A

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]

24.0

8.9

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.9

955

7908

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

8.9

631

4956

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

8.9

841

6861

K03.66

ICD-10 Finland

Tooth plaque

1.5

8.9

291

2008

SPAT1211

SPAT

Application of soft bandage

1.5

8.8

314

2200

M01AE02

ATC

naproxen; oral, rectal

1.2

8.8

2167

19561

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

8.8

298

2068

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

7.2

8.7

J35.8

ICD-10 Finland

Other chronic diseases of tonsils and adenoids

3.7

8.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

8.7

157

943

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

8.7

332

2359

SPAT1283

SPAT

Restricted health certificate

1.3

8.7

615

4827

TDB00

NOMESCO Finland

Removal of foreign body from external auditory canal

50.1

8.7

R21

ICPC

Throat symptom/complaint

1.3

8.7

826

6741

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

8.6

323

2285

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

8.6

560

4339

C01DA14

ATC

isosorbide mononitrate; oral

1.4

8.6

501

3818

RK120, ,

NOMESCO Finland

6.6

8.6

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.6

1505

13129

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

8.6

230

1519

N06AB10

ATC

escitalopram; oral

1.3

8.5

742

5983

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

8.5

298

2082

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

10.0

8.5

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

8.5

268

1834

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

8.5

297

2075

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.7

8.5

159

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

8.5

224

1477

RK320, ,

NOMESCO Finland

3.3

8.5

N03AX12

ATC

[U] gabapentin; oral

1.3

8.5

543

4201

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

8.5

114

629

H62.2

ICD-10 Finland

Otitis externa in mycoses

20.0

8.5

0601, ,

NOMESCO Finland

20.0

8.5

ZFX00

NOMESCO Finland

Use of balloon dilatation

20.0

8.5

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.5

8.5

200

SPAT1262

SPAT

Handing over of treatment supplies

1.3

8.4

585

4576

DDD10

NOMESCO Finland

Interposition between malleus and stapes

90.2

8.4

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

8.4

288

2004

S14

ICPC

Burn/scald

1.8

8.4

128

733

B01AC04

ATC

clopidogrel; oral

1.3

8.4

546

4233

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.5

8.4

195

P17

ICPC

Tobacco abuse

2.4

8.4

219

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

8.4

187

1186

R07.3

ICD-10 Finland

Other chest pain

1.4

8.4

367

2673

A01

ICPC

Pain general/multiple sites

1.4

8.4

364

2648

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.2

8.3

101

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

8.3

301

2116

EHC40

NOMESCO Finland

Repair of submucous cleft palate

+∞

8.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.3

1458

12715

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

8.5

8.3

A01AB09

ATC

miconazole; local oral

1.5

8.3

281

1952

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

8.3

171

1064

H91.1

ICD-10 Finland

Presbycusis

1.5

8.3

219

1445

N30.0

ICD-10 Finland

Acute cystitis

1.3

8.2

620

4905

N06AX21

ATC

duloxetine; oral

1.4

8.2

409

3042

SPAT1240

SPAT

Therapeutic discussion

1.4

8.2

376

2759

H60.2

ICD-10 Finland

Malignant otitis externa

14.5

8.2

R03DA04

ATC

theophylline; systemic, rectal

1.6

8.2

161

990

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

8.1

942

7859

P03

ICPC

Feeling depressed

1.4

8.1

387

2858

E000001, ,

ATC

1.3

8.1

699

5628

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

8.1

472

3599

R09

ICPC

Sinus symptom/complaint

1.4

8.1

296

2086

OAB50, ,

SPAT

1.5

8.1

275

1911

N07BA03

ATC

varenicline; oral

1.7

8.1

154

939

ECB17

NOMESCO Finland

Operation of gingival cleft

33.4

8.1

EAB30

NOMESCO Finland

Correction of cleft lip

33.4

8.1

DBD10

NOMESCO Finland

Reconstruction of external auditory canal

33.4

8.1

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

8.0

792

6490

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

7.2

7.9

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.9

755

6154

S97

ICPC

Chronic ulcer skin

1.5

7.9

214

1419

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

7.9

304

2163

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.9

946

7921

A28

ICPC

Limited function/disability NOS

1.3

7.9

618

4915

S10

ICPC

Boil/carbuncle

1.5

7.8

215

1430

S06.0

ICD-10 Finland

Concussion

1.4

7.8

384

2850

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

7.8

137

817

A98

ICPC

Health maint/preventive medicine

1.4

7.8

4197

40867

SPAT1216

SPAT

Assessment of functional ability

1.3

7.8

525

4090

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

9.4

7.8

ZZC00

NOMESCO Finland

Graft of fascia

9.4

7.8

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

7.8

788

6472

R04.0

ICD-10 Finland

Epistaxis

1.5

7.8

255

1761

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

7.8

1536

13533

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

7.7

462

3536

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

7.7

196

1282

Q35.71

ICD-10 Finland

Submucous cleft palate

45.1

7.7

4361

FHL

Lip plastic or reconstruction due to cleft lip

45.1

7.7

3890A

ICD-9 Finland

Deafness, Conductive deafness

45.1

7.7

H72

ICPC

Serous otitis media

15.0

7.7

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

7.7

298

R06AE09

ATC

levocetirizine; oral

1.3

7.7

502

3892

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.6

7.7

172

1092

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

7.7

294

2090

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

7.7

202

1332

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

2.4

7.7

210

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.2

7.6

273

WZA00

NOMESCO Finland

Concise certificate

1.5

7.6

234

1594

Z00.0

ICD-10 Finland

General medical examination

1.3

7.6

702

5698

UJF32

NOMESCO Finland

Coloscopy

1.2

7.6

898

7502

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.6

3717

35599

4741A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PALATINAE]

4.0

7.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

7.6

721

5873

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.9

7.6

506

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.1

7.5

R04.2

ICD-10 Finland

Haemoptysis

1.8

7.5

114

653

SPAT1097

SPAT

Recording of ECG

1.3

7.5

475

3666

J01CF05

ATC

flucloxacillin; systemic

1.5

7.5

250

1731

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.4

7.5

200

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

7.5

496

3856

P20

ICPC

Memory disturbance

1.3

7.4

471

3636

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

7.4

355

2624

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.9

7.4

425

DDA10

NOMESCO Finland

Exploration of ossicular chain

80.2

7.4

Q89.34

ICD-10 Finland

Cartagena syndrome (immotile cilia)

80.2

7.4

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

7.4

114

656

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

7.4

256

1786

SPAT1053

SPAT

Memory test

1.3

7.4

447

3429

A04

ICPC

Weakness/tiredness general

1.3

7.4

604

4831

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

7.3

181

1177

M25.5

ICD-10 Finland

Pain in joint

1.2

7.3

1195

10325

R81

ICPC

Pneumonia

1.7

7.3

131

787

L04AX03

ATC

methotrexate; systemic

1.4

7.3

323

2357

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.7

7.3

120

704

38299

ICD-8 Finland

Unspecified otitis media with mastoiditis

+∞

7.3

J01FA15

ATC

telithromycin; oral

1.4

7.3

307

2221

H93.9

ICD-10 Finland

Disorder of ear, unspecified

3.6

7.3

J01DB05

ATC

cefadroxil; oral

1.6

7.3

142

872

J45.8

ICD-10 Finland

Mixed asthma

1.8

7.3

102

571

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

7.3

808

6702

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

7.3

1061

9064

R75

ICPC

Sinusitis acute/chronic

1.6

7.2

166

1061

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.2

7.2

260

N06AX26

ATC

vortioxetine; oral

1.4

7.2

272

1928

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

7.2

326

H93.2

ICD-10 Finland

Other abnormal auditory perceptions

2.7

7.2

144

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.6

7.2

150

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

4.5

7.2

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.1

7.2

314

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

7.1

509

P15

ICPC

Chronic alcohol abuse

1.8

7.1

102

575

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.3

7.1

230

N06AB04

ATC

citalopram; systemic

1.3

7.1

699

5716

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

2.9

7.1

106

R13

ICD-10 Finland

Dysphagia

1.5

7.1

243

1693

M02AA07

ATC

piroxicam; topical

1.2

7.1

1197

10370

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

12.0

7.1

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.1

900

7577

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

7.0

205

1382

120

Kela drug reimbursment

Hypogammaglobulinaemia

8.8

7.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

7.0

389

2943

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.1

7.0

283

H92

ICD-10 Finland

Otalgia and effusion of ear

10.0

7.0

D07AA02

ATC

hydrocortisone; topical

1.3

7.0

491

3844

N01

ICPC

Headache

1.3

7.0

435

3348

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

7.0

239

1665

J01FA01

ATC

erythromycin; systemic

1.3

7.0

463

3598

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

7.0

214

1459

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

6.9

364

2731

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

6.9

235

1635

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

6.9

718

5908

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.0

6.9

332

N05BA01

ATC

diazepam; systemic, rectal

1.3

6.9

422

3242

XF402

NOMESCO Finland

ECG with work load test

1.4

6.9

329

2434

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.8

387

2938

J01MA06

ATC

norfloxacin; oral

1.3

6.8

409

3132

ZYC04

NOMESCO Finland

Remote contact, IT assisted

3.3

6.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

6.8

883

7444

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

6.7

6.8

OAA68, ,

SPAT

2.2

6.8

235

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.3

6.8

216

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

6.7

267

1912

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.7

1059

9105

L01

ICPC

Neck symptom/complaint

1.3

6.7

584

4703

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

6.7

476

N02AA05

ATC

oxycodone; systemic

1.3

6.7

615

4985

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

6.7

162

1050

L30.4

ICD-10 Finland

Erythema intertrigo

2.2

6.7

256

F03

ICPC

Eye discharge

1.4

6.7

242

1706

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

6.7

192

1293

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

6.6

310

2283

S15

ICPC

Foreign body in skin

1.5

6.6

222

1540

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

6.6

227

1582

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

6.6

125

763

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.6

1243

10870

SPAT1351

SPAT

Extensive ear examination

2.9

6.6

100

602

Kela drug reimbursment

Children's severe malnutrition

4.2

6.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

6.5

291

2127

S02CA06

ATC

dexamethasone and antiinfectives; otic

3.0

6.5

EMB15

NOMESCO Finland

Partial tonsillectomy

10.0

6.5

L16

ICPC

Ankle symptom/complaint

1.3

6.5

433

3366

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

6.5

157

1017

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.5

6.5

167

1097

R50.9

ICD-10 Finland

Fever, unspecified

1.3

6.5

543

4351

L04AA01

ATC

[U] ciclosporin

2.3

6.5

201

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

6.5

255

1824

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.0

6.5

313

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

6.5

431

3352

A01AB04

ATC

amphotericin B; local oral

1.6

6.5

136

853

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

6.2

6.5

K08.3

ICD-10 Finland

Retained dental root

1.4

6.4

250

1784

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

6.4

249

1776

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

6.4

633

5174

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.4

280

2039

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

6.4

155

1004

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.5

6.4

159

F29

ICPC

Eye symptom/complaint other

1.3

6.4

371

2827

4452

FHL

Tonsil surgery

1.7

6.4

572

RK530, ,

NOMESCO Finland

14.3

6.4

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

6.4

412

3190

DHB10

NOMESCO Finland

Excision of lesion of internal nose

4.1

6.3

S50.0

ICD-10 Finland

Contusion of elbow

1.7

6.3

108

642

J01EA01

ATC

trimethoprim; systemic

1.2

6.3

875

7425

J33.9

ICD-10 Finland

Nasal polyp, unspecified

2.3

6.3

198

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.5

6.3

162

1066

XQ800

NOMESCO Finland

Prick test

1.4

6.3

240

1709

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

6.3

319

2384

H74.8

ICD-10 Finland

Other specified disorders of middle ear and mastoid

18.0

6.3

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

6.3

752

6285

4146

FHL

Radical cutting (bridge broken)

+∞

6.2

DED00

NOMESCO Finland

Obliteration of cavity after partial excision of mastoid

+∞

6.2

3829X

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified otitis media

+∞

6.2

DGW99

NOMESCO Finland

Other operation on eustachian tube

+∞

6.2

Q35.3

ICD-10 Finland

Cleft soft palate

+∞

6.2

N02BF01

ATC

gabapentin; oral

1.3

6.2

346

2620

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

6.2

277

2025

S01

ICPC

Pain/tenderness of skin

1.5

6.2

164

1084

R44

ICPC

Respiratory, Preventive immunization/medic

2.1

6.2

244

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

2.4

6.2

174

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

6.2

122

754

SPAT1058

SPAT

PEF monitoring instruction

1.4

6.2

260

1884

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

6.2

113

685

DMB10

NOMESCO Finland

Radical maxillary antrotomy

3.5

6.1

-31

ICPC

Medical examin/health eval partial

1.4

6.1

227

1606

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

6.1

217

1523

J37.0

ICD-10 Finland

Chronic laryngitis

1.7

6.1

107

640

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

6.1

442

3475

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

2.7

6.1

110

A10AE04

ATC

insulin glargine; parenteral

1.4

6.1

315

2360

N17

ICPC

Vertigo/dizziness

1.3

6.1

452

3567

R06.2

ICD-10 Finland

Wheezing

1.6

6.1

150

977

A46

ICD-10 Finland

Erysipelas

1.3

6.1

478

3800

D05AX52

ATC

calcipotriol, combinations; topical

1.5

6.1

168

1122

H25.8

ICD-10 Finland

Other senile cataract

1.3

6.1

354

2701

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

6.1

364

2789

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

6.1

145

938

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.1

509

4081

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.7

6.0

537

WX199

NOMESCO Finland

Other local analgesia

1.7

6.0

111

673

R03BA01

ATC

beclometasone; inhalant

1.3

6.0

447

3527

50499

ICD-8 Finland

Deflected nasal septum

2.1

6.0

234

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.0

480

3824

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.0

888

7579

M02AA10

ATC

ketoprofen; topical

1.3

6.0

512

4113

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

1349

4590

3.78

307.65

2.5

1.7

—

(3000494) Fungus identified in Specimen by Culture

941

4717

2.26

96.71

1.9

1.5

—

(3042936) Bacteria identified in Isolate by Culture

1010

5568

2.05

79.46

2.2

2.0

—

(3013115) Eosinophils [#/volume] in Blood

2531

20995

1.47

34.06

7.7

6.6

0.21

0.19

e9/l

3.83

2198

18323

(3018010) Neutrophils/Leukocytes in Blood

2310

18861

1.47

33.47

7.4

6.4

56.87

57.10

0.42

2186

18062

(3019198) Lymphocytes [#/volume] in Blood

2504

20825

1.46

32.57

7.5

6.4

1.92

1.93

e9/l

0.14

2210

18320

(3019069) Monocytes/Leukocytes in Blood

2293

18766

1.46

32.37

7.9

6.6

8.85

8.82

0.14

2135

17650

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3251

28526

1.51

31.75

5.4

4.3

12.80

11.84

mm/h

3.15

3017

26735

(3006315) Basophils [#/volume] in Blood

2452

20387

1.45

31.42

7.4

6.3

0.04

e9/l

1.74

2126

17495

(3006504) Eosinophils/Leukocytes in Blood

2282

18721

1.45

31.42

7.8

6.5

2.97

2.83

2.15

2122

17589

(3001604) Monocytes [#/volume] in Blood

2445

20335

1.45

31.17

7.4

6.3

0.60

0.58

e9/l

2.07

2118

17458

(3022096) Basophils/Leukocytes in Blood

2278

18700

1.44

31.14

7.9

6.6

0.69

0.68

0.70

2116

17564

(3002030) Lymphocytes/Leukocytes in Blood

2328

19251

1.44

30.20

7.7

6.5

28.12

28.00

0.19

2205

18282

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3323

29418

1.50

29.92

9.6

8.3

80.53

79.56

u/l

0.56

3152

27990

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2364

19640

1.43

29.66

8.9

7.3

1.21

mmol/l

0.38

2064

16992

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2442

20408

1.43

29.66

7.1

6.6

11.83

11.53

umol/l

0.31

2306

19455

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2148

17602

1.42

28.71

8.0

6.6

1.21

mmol/l

0.18

1969

16307

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1599

12427

1.45

28.57

2.9

2.7

54.79

66.47

u/l

1.13

1482

11535

(3013826) Glucose [Moles/volume] in Serum or Plasma

2691

22977

1.43

28.45

6.1

5.1

6.73

6.67

mmol/l

0.66

2541

21704

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4055

37861

1.76

26.42

20.4

15.8

23.41

24.06

mg/l

0.63

3449

31109

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2082

17185

1.40

25.54

2.3

2.1

95.72

96.40

pmol/l

0.24

1104

9161

(3032080) INR in Blood by Coagulation assay

2124

17632

1.39

24.97

15.6

15.2

1.25

1.26

inr

0.25

1781

14743

(3013650) Neutrophils [#/volume] in Blood by Automated count

2643

22755

1.40

24.93

10.7

9.6

4.23

4.10

e9/l

1.21

2308

19707

(3019309) Folate [Moles/volume] in Red Blood Cells

902

6452

1.50

23.91

1.8

1.7

1115.41

1161.33

nmol/l

0.73

667

4894

(3024561) Albumin [Mass/volume] in Serum or Plasma

2093

17484

1.37

22.92

5.8

5.1

35.78

35.76

g/l

0.05

1968

16431

(3031040) Bacteria [#/volume] in Urine by Automated count

2912

25660

1.39

22.75

5.4

4.7

1104.51

1637.41

e6/l

0.29

349

(3023368) Bacteria identified in Blood by Culture

1379

10829

1.40

21.76

4.8

4.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1364

10771

1.38

20.56

2.5

2.3

2.77

2.79

mg/l

0.14

1171

9326

(3019225) pH of Specimen

547

3621

1.58

20.42

4.2

4.3

7.37

7.35

1.12

385

2602

(3019550) Sodium [Moles/volume] in Serum or Plasma

4038

38075

1.63

20.07

23.3

18.5

139.55

139.65

mmol/l

1.53

3954

37317

(3023103) Potassium [Moles/volume] in Serum or Plasma

4044

38148

1.63

20.03

23.5

18.7

3.97

mmol/l

0.06

3956

37320

(3005719) IgG [Mass/volume] in Serum or Plasma

477

3101

1.60

19.18

3.8

2.7

10.18

10.58

g/l

1.01

443

2853

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2941

26277

1.35

18.98

3.7

3.3

50.56

46.93

u/l

1.21

2771

24768

(3009445) Proteinase 3 Ab [Units/volume] in Serum

288

1650

1.80

18.55

3.0

1.5

16.90

14.48

iu/ml

0.13

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

269

1511

1.83

18.49

2.2

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

895

6690

1.42

18.26

2.2

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

411

2608

1.63

18.21

1.5

1.3

266.65

244.01

u/ml

0.12

381

2409

(3026008) Bacteria identified in Urine by Culture

1476

11986

1.35

18.07

3.6

3.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2102

18000

1.32

17.65

2.8

2.5

75.88

76.70

nmol/l

0.69

1890

16402

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2137

18399

1.31

17.01

3.2

2.8

—

estimate

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

247

1400

1.81

16.49

1.7

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4178

39988

1.69

16.45

25.4

20.3

78.40

77.18

umol/l

1.25

4122

39517

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1458

11951

1.33

16.35

2.3

2.2

180.08

222.95

u/l

1.24

1372

11333

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

244

1390

1.80

16.02

2.1

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1720

14471

1.31

15.85

4.3

3.8

104.38

86.57

ng/l

0.11

1208

9931

(3047181) Lactate [Moles/volume] in Blood

211

1154

1.87

15.80

5.6

6.4

1.44

1.32

mmol/l

0.79

190

1017

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3762

35277

1.42

15.77

5.9

5.4

1.99

1.90

mu/l

0.41

3458

32839

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

622

4458

1.46

15.73

5.1

4.8

32.46

0.00

389

2984

(3017732) Neutrophils [#/volume] in Blood

675

4931

1.43

15.39

3.3

4.07

4.68

e9/l

2.64

546

4298

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1589

13271

1.31

15.32

3.8

3.3

33.00

34.58

u/l

0.36

1497

12523

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1374

11257

1.32

15.21

3.4

3.2

1425.61

1379.95

ng/l

0.15

1173

9712

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4147

39726

1.61

14.89

14.4

11.9

27.58

26.05

u/l

2.99

4018

38640

(3003458) Phosphate [Moles/volume] in Serum or Plasma

711

5299

1.41

14.42

6.8

6.3

1.06

1.05

mmol/l

0.20

657

4942

(3021960) Folate [Moles/volume] in Serum or Plasma

1365

11244

1.31

14.35

1.9

1.7

20.01

20.16

nmol/l

0.14

1159

9623

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3269

30138

1.32

14.14

4.7

4.4

14.80

14.75

pmol/l

0.59

2966

27720

(3007461) Platelets [#/volume] in Blood

4274

41318

1.78

14.13

30.1

24.0

252.39

251.75

e9/l

0.26

4197

40480

(3028026) IgM [Mass/volume] in Serum or Plasma

371

2442

1.57

14.05

2.1

1.9

1.24

1.34

g/l

0.62

343

2249

(3010813) Leukocytes [#/volume] in Blood

4275

41339

1.78

14.00

30.1

24.0

6.98

6.75

e9/l

4.76

4186

40378

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4274

41327

1.78

13.99

30.0

23.9

90.93

90.85

0.59

4221

40897

(3035941) MCH [Entitic mass]

4274

41327

1.78

13.99

30.0

23.8

30.26

0.09

4221

40895

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4274

41331

1.78

13.93

30.7

24.4

40.04

40.87

2.94

4221

40887

(3026361) Erythrocytes [#/volume] in Blood

4274

41333

1.78

13.90

30.1

23.9

4.47

4.50

e12/l

4.01

4180

40390

(3000963) Hemoglobin [Mass/volume] in Blood

4274

41342

1.77

13.76

30.3

24.1

134.14

135.15

g/l

4.53

4224

40925

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

223

1301

1.75

13.53

3.7

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

393

2650

1.53

13.34

5.1

3.8

5.12

5.15

kpa

0.37

380

2540

(3044640) Blood type and Crossmatch panel - Blood

1528

12878

1.28

13.23

2.8

2.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3785

35757

1.38

13.20

5.5

5.0

5.93

5.89

mmol/l

0.96

3472

32972

(3035350) Ketones [Presence] in Urine by Test strip

2363

21008

1.26

13.10

4.4

3.9

3.60

4.43

estimate

0.08

429

4499

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

137

691

2.01

13.08

1.7

1.2

152.86

302.00

titre

—

(3013512) EKG study

1523

12850

1.28

13.01

4.2

3.6

—

0.72

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1480

12455

1.28

12.88

4.4

4.2

9.37

8.87

mg/mmol

0.14

945

7860

(3037522) Nuclear Ab [Titer] in Serum

728

5562

1.37

12.58

1.4

585.12

539.78

titre

0.23

164

1187

(3009261) Glucose [Presence] in Urine by Test strip

2369

21134

1.26

12.48

4.4

3.9

0.00

0.08

estimate

0.58

407

4230

(3022313) Gas panel - Capillary blood

284

1807

1.61

12.42

5.1

4.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

134

686

1.98

12.29

1.7

1.2

170.67

415.27

titre

1.40

(3021601) Nitrite [Presence] in Urine by Test strip

2328

20775

1.25

12.04

4.4

3.9

0.00

estimate

0.80

423

4412

(3009343) pH of Capillary blood

377

2581

1.50

11.90

5.2

3.8

7.41

0.04

324

2132

(3023520) Reticulocytes [#/volume] in Blood

490

3555

1.42

11.44

3.0

2.6

70.47

69.03

e9/l

0.35

373

2570

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

185

1077

1.75

11.35

1.8

1.4

34.24

11.03

iu/ml

—

(3015736) pH of Urine

1918

16841

1.24

11.13

3.9

3.5

6.21

6.25

0.81

1036

9454

(3009508) Creatinine [Moles/volume] in Urine

1567

13467

1.25

10.99

3.9

3.5

7.38

7.60

mmol/l

1.16

1326

11468

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

196

1175

1.70

10.84

1.4

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

859

6864

1.31

10.81

3.0

2.6

12.67

13.15

umol/l

1.17

809

6417

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

333

2270

1.50

10.73

5.2

3.7

1.68

1.80

mmol/l

0.26

242

1667

(3039000) Anion gap in Blood by calculation

144

795

1.84

10.57

6.5

7.5

11.48

11.29

mmol/l

0.28

129

711

(3018572) Chloride [Moles/volume] in Blood

144

796

1.84

10.53

6.5

7.5

104.80

105.22

mmol/l

0.43

129

712

(3012516) Albumin [Mass/volume] in Urine

1430

12219

1.25

10.41

3.7

3.5

45.98

48.80

mg/l

0.19

930

7897

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3688

34980

1.31

10.36

6.9

6.2

39.44

39.00

mmol/mol

2.21

3425

32849

(3045424) Erythrocytes [Presence] in Urine

288

1919

1.54

10.33

2.0

2.1

0.16

0.42

estimate

0.26

601

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

404

2888

1.44

10.22

1.9

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

331

2281

1.49

10.12

11.1

10.1

15.96

15.99

0.09

316

2200

(3008152) Bicarbonate [Moles/volume] in Arterial blood

344

2395

1.47

9.99

6.5

6.7

24.23

24.47

mmol/l

0.51

328

2290

(3007930) Methemoglobin/Hemoglobin.total in Blood

249

1624

1.56

9.84

5.9

5.4

0.92

0.88

1.07

237

1535

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

400

2879

1.43

9.74

1.6

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

376

2.18

9.72

4.4

3.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

797

6392

1.30

9.66

3.0

2.6

2.39

2.33

g/l

2.37

738

5926

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1166

9807

1.26

9.60

2.7

2.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

117

625

1.90

9.56

4.3

3.6

1.00

1.57

1.47

109

554

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

226

1452

1.59

9.54

5.4

4.1

24.76

24.75

mmol/l

0.01

214

1345

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

413

3012

1.41

9.34

3.3

3.0

167.15

195.36

ng/l

0.92

376

2742

(3018677) aPTT in Platelet poor plasma by Coagulation assay

754

6029

1.30

9.32

2.1

2.2

29.39

29.68

0.53

729

5858

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

268

2.37

9.30

2.6

2.7

219.22

212.42

e6/l

0.12

229

(3028433) Virus identified in Specimen by Culture

120

3.10

9.19

1.5

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

560

4303

1.34

9.16

6.7

6.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2152

19374

1.21

9.12

3.6

3.1

122.09

119.08

ug/l

0.18

2001

18168

(3026493) Urate [Moles/volume] in Serum or Plasma

1186

10045

1.25

9.10

2.8

2.7

343.50

342.22

umol/l

0.15

1047

8880

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1038

8660

1.26

9.10

1.8

1.08

1.28

mg/l

1.77

796

6642

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3893

37341

1.33

9.08

5.9

5.6

2.65

2.70

mmol/l

3.65

3598

34900

(3024980) IgG subclass 4 [Mass/volume] in Serum

118

644

1.85

9.04

1.7

1.6

0.89

0.76

g/l

0.38

514

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

239

1577

1.54

8.99

1.9

1.14

2.17

ug/l

1.43

208

1396

(4062490) Immunoglobulin typing, IgG

375

2.13

8.99

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

734

5884

1.30

8.87

3.1

2.6

21.02

22.69

3.36

688

5480

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

633

4974

1.32

8.86

2.0

1.8

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3750

35812

1.29

8.84

18.4

15.4

82.37

82.54

ml/min/173m2

0.17

3446

32943

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

595

4638

1.33

8.82

2.9

2.8

10.33

7.97

umol/l

0.82

514

4049

(3027135) IgG subclass 1 [Mass/volume] in Serum

378

2.11

8.82

1.3

1.4

6.26

6.78

g/l

0.78

277

(3024139) IgG subclass 3 [Mass/volume] in Serum

378

2.11

8.82

1.3

1.4

0.36

0.40

g/l

0.58

277

(3028192) IgG subclass 2 [Mass/volume] in Serum

378

2.11

8.82

1.3

1.4

3.09

2.95

g/l

0.27

277

(3027945) Reticulocytes/Erythrocytes in Blood

596

4648

1.33

8.80

3.0

2.6

1.89

1.77

1.50

518

4145

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

597

4663

1.32

8.72

4.6

4.4

231.80

243.33

u/l

1.50

564

4423

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

414

3058

1.39

8.69

4.4

4.0

86.90

87.55

ng/l

0.05

365

2648

(3027801) Oxygen [Partial pressure] in Arterial blood

589

4604

1.32

8.55

9.1

7.7

11.81

12.45

kpa

2.47

563

4432

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

589

4604

1.32

8.55

9.1

7.7

5.07

5.09

kpa

0.23

565

4435

(40768797) Stomach Pathology biopsy report

673

5361

1.30

8.51

1.2

—

(3003396) Base excess in Arterial blood by calculation

585

4574

1.32

8.47

9.0

7.6

0.92

0.91

mmol/l

0.01

471

3765

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

966

8052

1.25

8.45

1.7

75246736.98

27265087.19

pmol/l

1.15

812

6756

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

259

1766

1.50

8.37

5.7

5.2

1.64

1.62

0.09

247

1671

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3839

36829

1.30

8.35

5.2

4.9

4.52

4.61

mmol/l

6.19

3564

34562

(3019977) pH of Arterial blood

587

4604

1.32

8.31

9.2

7.7

7.42

1.24

325

2499

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

597

4694

1.31

8.30

2.0

1.8

—

(3023419) Bacteria identified in Sputum by Culture

512

1.91

8.27

4.3

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

232

1555

1.52

8.15

1.3

1.2

1.37

1.15

u/ml

0.10

113

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

909

7554

1.26

8.13

4.4

3.9

273.38

545.05

ng/l

1.20

699

5828

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

266

2.27

8.11

2.5

2.6

488.15

514.00

e6/l

0.17

216

(3030981) Hyaline casts [#/volume] in Urine by Automated count

424

3180

1.37

8.10

2.8

2.5

0.35

0.44

e6/l

0.47

405

3033

(3015377) Calcium [Moles/volume] in Serum or Plasma

1537

13501

1.21

8.09

3.6

3.5

2.35

mmol/l

1.73

1372

12324

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3815

36600

1.29

8.07

5.2

4.8

1.42

1.45

mmol/l

6.70

3523

34161

(3020779) Urea [Moles/volume] in Serum or Plasma

478

3662

1.34

7.96

9.0

7.6

10.28

9.78

mmol/l

0.73

456

3523

(3012095) Magnesium [Moles/volume] in Serum or Plasma

804

6610

1.26

7.86

3.9

3.5

0.81

0.82

mmol/l

0.58

757

6226

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

283

2.21

7.83

2.6

2.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.05

7.79

1.2

57.49

75.05

ng/l

0.16

(3017354) Segmented neutrophils/Leukocytes in Blood

412

1.98

7.71

4.2

3.6

60.48

57.40

0.63

353

(3016502) Oxygen saturation in Arterial blood

525

4100

1.32

7.65

9.4

8.0

95.45

95.59

0.22

502

3958

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3645

34833

1.25

7.60

4.4

4.1

1.31

1.28

mmol/l

2.23

3334

32217

(4015189) Microbial culture of sputum

3.39

7.51

1.9

2.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

493

3827

1.32

7.49

10.1

8.5

120.76

121.71

g/l

0.48

480

3740

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

941

7915

1.24

7.49

1.7

1.6

—

(3019150) Specific gravity of Urine by Refractometry

1094

9350

1.23

7.48

4.5

4.1

2.37

1.34

kg/l

0.34

748

6223

(3018418) pH of Serum or Plasma

1351

11792

1.21

7.47

4.7

4.2

7.40

0.25

983

8434

(3036481) Cortisol [Moles/volume] in Serum or Plasma

502

3911

1.32

7.43

2.5

2.2

378.58

379.03

nmol/l

0.01

468

3614

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1130

9696

1.22

7.42

1.4

1.3

1.32

1.66

u/ml

0.75

279

2611

(3011412) CD3 cells [#/volume] in Blood

377

2.01

7.40

2.6

2.5

1108.83

1181.16

e6/l

0.40

330

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

184

2.46

7.31

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

184

2.46

7.31

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

184

2.46

7.31

1.6

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

184

2.46

7.31

1.6

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

100

556

1.82

7.30

1.6

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

551

1.81

7.21

1.3

1.2

59.40

13.35

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

859

7181

1.24

7.21

1.4

1.3

36.35

30.26

iu/ml

0.44

257

2146

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2699

25129

1.19

7.03

3.3

3.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

443

3419

1.33

7.01

4.6

4.3

0.53

0.68

0.91

169

997

(3007164) IgA [Mass/volume] in Serum or Plasma

992

8445

1.22

6.99

1.7

1.5

2.39

2.40

g/l

0.01

638

5238

(3000093) Morphology [Interpretation] in Blood Narrative

372

1.98

6.96

1.2

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

313

2.06

6.83

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

313

2.06

6.83

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

313

2.06

6.83

1.6

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

179

1181

1.54

6.81

1.7

0.24

0.23

g/l

0.31

171

1124

(3014051) Protein [Presence] in Urine by Test strip

1289

11291

1.20

6.72

3.3

3.0

0.09

0.04

0.21

261

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

491

1.83

6.70

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

197

1338

1.49

6.56

1.6

1.5

0.50

5.65

iu/ml

0.52

244

(3027273) Bicarbonate [Moles/volume] in Venous blood

249

1772

1.43

6.51

5.1

3.4

25.48

25.24

mmol/l

0.44

241

1708

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

158

1025

1.56

6.50

1.7

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

458

3591

1.31

6.47

4.7

4.4

0.81

0.88

0.19

179

1054

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

483

1.82

6.43

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.93

6.41

1.3

1.1

—

(3037121) Protein [Mass/volume] in Urine

201

1379

1.48

6.37

3.3

3.5

424.26

402.48

mg/l

0.07

616

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

109

651

1.69

6.27

2.9

1.3

20.99

12.60

u/ml

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

104

617

1.70

6.14

1.7

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

506

1.77

6.10

1.3

303.88

321.01

pmol/l

0.21

428

(3020191) Ethanol [Moles/volume] in Serum or Plasma

328

1.97

6.05

1.9

1.5

1.03

1.20

promille

0.36

261

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

400

3112

1.31

5.99

2.4

5.40

7.18

ug/l

1.77

334

2751

(3012544) pH of Venous blood

527

4254

1.27

5.94

5.0

3.9

7.37

7.38

0.67

320

2465

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

481

3839

1.28

5.94

2.2

2.3

0.21

g/l

0.04

449

3587

(3014271) Vancomycin [Susceptibility]

166

2.36

5.88

3.1

2.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

463

1.79

5.77

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

486

1.76

5.74

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

286

2.01

5.74

1.2

—

(3002032) Base excess in Venous blood by calculation

508

4100

1.27

5.73

5.1

3.9

1.71

1.80

mmol/l

0.22

452

3567

(3045414) Leukocytes [Presence] in Urine

471

3768

1.28

5.71

2.1

0.04

0.01

estimate

0.47

805

(3000060) B lymphocytes [#/volume] in Blood

109

2.67

5.65

2.2

2.3

0.14

0.16

e9/l

0.21

(3021440) Promyelocytes/Leukocytes in Blood

433

3433

1.29

5.64

4.7

4.5

0.13

0.11

0.18

154

900

(3005988) Vibrio sp identified in Specimen by Organism specific culture

467

1.77

5.62

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1444

12938

1.17

5.57

3.8

3.4

40.08

87.49

e6/l

2.42

1136

9809

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

808

1.58

5.51

6.2

292.64

2442.98

iu/ml

0.61

120

(1761868) Lipid panel - Serum or Plasma

1321

14746

0.85

5.49

3.2

3.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

177

1223

1.47

5.46

1.8

1.7

1.18

g/l

0.02

169

1167

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

122

780

1.58

5.41

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

466

1.75

5.38

1.6

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

784

6677

1.21

5.38

1.3

13.60

10.54

u/ml

0.51

273

2581

(3021447) Carbon dioxide [Partial pressure] in Venous blood

516

4211

1.25

5.30

5.2

3.8

5.88

5.82

kpa

0.65

502

4102

(3025159) Blasts/Leukocytes in Blood

434

3475

1.28

5.23

4.9

4.6

0.05

0.18

0.75

144

850

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

150

2.34

5.23

1.0

1.1

9.01

8.10

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

145

2.36

5.14

1.4

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

1014

8879

1.18

5.10

3.0

2.7

6.52

5.83

e6/l

0.59

927

8070

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

139

932

1.51

5.01

1.3

1.2

14.67

3.12

u/ml

0.43

(3004616) Nuclear Ab [Presence] in Serum

507

1.69

4.99

1.3

—

(40758558) Short blood count panel - Blood

1325

11876

1.16

4.97

7.1

6.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

479

1.70

4.91

1.3

0.19

0.22

nmol/l

0.40

380

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

173

1217

1.44

4.90

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

171

1201

1.44

4.89

1.3

14.28

42.19

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

1288

11545

1.16

4.80

4.5

4.0

0.00

estimate

1.74

403

4072

(3048689) Calprotectin [Mass/mass] in Stool

642

5423

1.21

4.77

2.6

2.5

155.31

132.04

ug/g

0.71

517

4343

(3004119) Hemoglobin [Mass/volume] in Venous blood

324

2530

1.30

4.76

4.7

3.2

128.70

129.47

g/l

0.22

314

2458

(3011397) Hemoglobin [Presence] in Urine by Test strip

1088

9638

1.17

4.71

4.1

3.8

0.80

0.10

—

101

(3011985) Renin [Units/volume] in Plasma

539

1.65

4.70

1.6

1.5

56.73

72.62

mu/l

0.36

478

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

136

922

1.49

4.67

1.7

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

267

2037

1.33

4.64

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

418

3382

1.26

4.64

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

161

1130

1.44

4.64

1.4

1.3

13.59

3.46

u/ml

0.62

103

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

314

2452

1.30

4.62

1.9

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

140

2.29

4.60

3.2

2.2

202.50

25291.20

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

161

1132

1.44

4.59

1.2

1.3

54.55

91.08

titre

3.11

102

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1715

15734

1.15

4.58

4.4

3.8

1.47

0.21

estimate

0.41

346

3622

(4024509) Urine culture

242

1825

1.34

4.55

2.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.98

4.55

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.98

4.55

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.98

4.55

1.5

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

141

2.28

4.53

1.8

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

141

2.28

4.53

1.8

2.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

546

1.62

4.48

1.3

0.58

3.85

nmol/l

0.51

526

(3018095) Leukocytes [#/volume] in Urine

1624

14861

1.15

4.48

4.6

4.0

78.20

91.42

e6/l

0.48

1183

10360

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

142

2.26

4.46

1.8

2.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

299

1.85

4.46

1.6

1.3

1.26

2.27

u/ml

0.55

166

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

153

1072

1.44

4.46

1.8

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

167

1190

1.42

4.44

1.4

247.55

279.82

ug/g

1.20

678

(3044927) Protein electrophoresis panel - Urine

380

1.75

4.44

1.2

—

(3025941) Bacteria identified in Stool by Culture

280

2167

1.31

4.41

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

595

5028

1.21

4.40

1.7

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1254

11282

1.15

4.38

5.8

5.5

2.69

3.22

ug/l

0.53

1109

10226

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

273

1.88

4.35

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

159

1129

1.42

4.32

1.3

12.22

10.06

u/ml

0.14

178

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

647

1.56

4.29

4.0

3.1

5881.11

1679.38

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

253

1941

1.32

4.25

2.5

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

462

1.66

4.22

1.2

1.4

—

nmol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

269

1.87

4.21

1.4

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

404

3294

1.25

4.21

3.3

2.7

65.79

66.43

g/l

0.95

364

3035

(3027923) C peptide [Moles/volume] in Serum or Plasma

227

1.95

4.19

1.6

1.4

1.34

1.23

nmol/l

0.20

167

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

191

1410

1.37

4.15

2.3

2.2

1318.60

466.04

ug/l

0.38

178

1330

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.89

4.12

2.0

1.3

4.26

4.20

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.89

4.12

2.0

1.3

0.09

0.54

mg/l

—

(3023183) Ammonium ion [Moles/volume] in Plasma

126

865

1.47

4.11

2.3

2.8

36.47

35.06

umol/l

0.16

108

786

(3023420) DNA double strand Ab [Units/volume] in Serum

220

1664

1.34

4.09

1.8

4.56

6.66

iu/ml

1.29

406

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

244

1875

1.32

4.07

1.9

1.8

1.49

1.52

g/l

0.23

211

1632

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

274

2140

1.30

4.06

3.9

2.9

1.30

1.21

0.85

274

2122

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

155

1115

1.40

3.95

1.5

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

566

1.57

3.91

1.3

0.14

0.35

nmol/l

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

298

1.79

3.90

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

125

2.25

3.89

4.2

2.8

4.79

4.80

kpa

0.02

125

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

125

2.25

3.89

4.2

2.8

10.96

10.46

kpa

0.58

125

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

145

1034

1.42

3.89

1.1

18.57

4.50

eliau/ml

—

130

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

2.23

3.82

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

228

1.89

3.81

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1706

15789

1.13

3.79

2.0

1.9

1.39

1.35

mmol/l

1.17

1420

13422

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

268

2113

1.29

3.72

3.8

2.8

0.63

0.62

0.26

268

2099

(3041096) Erythrocytes [Presence] in Urine by Automated

1249

11343

1.14

3.72

3.9

3.3

0.09

0.12

estimate

0.08

348

3473

(3042631) Mycobacterium sp identified in Specimen

487

1.59

3.69

3.2

2.8

—

(3000034) Microalbumin [Mass/volume] in Urine

311

1.75

3.69

2.6

3.0

51.95

40.67

mg/l

0.19

233

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

224

1.88

3.67

1.3

—

(3037756) Immunofixation for Serum or Plasma

116

803

1.46

3.67

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

795

6997

1.17

3.67

1.8

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

118

820

1.45

3.66

1.6

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

268

1.80

3.64

3.2

3.3

160.67

220.05

nmol/l

0.26

263

(3006184) Hemoglobin [Mass/volume] in Capillary blood

135

964

1.41

3.62

2.9

2.2

127.06

129.74

g/l

0.59

101

759

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

773

1.46

3.60

1.7

1.4

—

(3026782) Osmolality of Urine

861

7636

1.16

3.59

3.3

2.9

536.67

531.98

mosm/kgh2o

0.24

759

6698

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

356

4310

0.81

3.54

1.9

3.58

3.50

ratio

0.48

269

3272

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

219

1694

1.31

3.53

1.9

40.12

39.67

u/l

0.11

191

1522

(3049717) Cytology report of Urine Cyto stain

183

1386

1.33

3.43

3.0

2.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

428

1.60

3.36

2.5

2.4

1.19

mmol/l

0.30

420

(3022621) pH of Urine by Test strip

375

3114

1.22

3.34

2.8

2.7

6.05

6.09

0.44

243

2086

(3041354) Potassium [Moles/volume] in Venous blood

438

1.58

3.30

2.5

2.4

4.07

4.05

mmol/l

0.07

430

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

551

1.52

3.26

1.3

1.4

19.96

24.52

u/l

0.67

467

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

456

1.57

3.24

2.1

2.2

20.96

22.36

mg/l

0.13

161

(40760892) CBC W Ordered Manual Differential panel - Blood

1005

9077

1.14

3.20

5.6

4.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.37

3.18

6.4

8.3

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

229

1.80

3.15

2.7

2.8

39.50

42.75

0.78

126

(46235355) HIV 1 and 2 tests - Meaningful Use set

934

8410

1.14

3.11

2.1

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

566

4914

1.17

3.10

2.0

1.8

1.49

1.45

0.93

500

4334

(3022145) Colonoscopy Study observation

513

4420

1.18

3.08

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

438

1.56

3.08

2.5

2.4

104.82

105.43

mmol/l

0.42

430

(3003327) Ova and parasites identified in Stool by Light microscopy

188

1454

1.31

3.07

1.8

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

261

1.73

3.06

2.4

2.7

0.60

0.64

e9/l

0.27

250

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

129

946

1.37

3.02

1.4

26.15

20.79

e6/l

0.11

101

701

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

147

1101

1.35

3.01

1.4

535.32

539.30

mg/l

0.02

138

1045

(3024354) Oxygen [Partial pressure] in Venous blood

419

3557

1.20

2.99

4.6

3.3

4.77

4.58

kpa

0.93

407

3457

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

161

1.93

2.99

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.85

2.97

1.5

1.1

0.80

1.26

iu/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

327

2713

1.22

2.96

2.4

16.28

20.38

au/ml

0.86

280

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

304

2505

1.23

2.94

1.3

45.23

50.50

au/ml

0.18

165

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

121

2.07

2.92

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

243

1.74

2.89

1.1

1.12

1.11

u/l

0.04

107

(4027681) Cerebrospinal fluid IgG ratio and IgG index

258

1.71

2.89

1.2

0.80

0.62

ratio

0.70

151

(40768443) Skin Pathology biopsy report

216

1717

1.27

2.88

1.2

—

(3008898) HLA-B27 [Presence]

181

1407

1.30

2.87

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

101

717

1.42

2.87

1.8

1.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

415

1.55

2.84

1.7

1.6

54.82

58.50

0.30

266

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

384

1.57

2.82

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

121

890

1.37

2.80

1.3

1.2

51.13

38.83

u/ml

0.33

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

129

961

1.35

2.76

1.1

2.79

2.54

u/ml

0.07

528

(3010838) Calcium [Moles/time] in 24 hour Urine

682

1.42

2.73

1.9

5.03

4.96

mmol/24h

0.06

596

(44816559) Phosphatidylethanol [Mass/volume] in Blood

219

1757

1.26

2.72

1.6

1.7

0.28

0.31

mg/l

0.32

103

808

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

160

1.88

2.70

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

160

1.88

2.70

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

125

2.01

2.70

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

373

1.56

2.69

1.2

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.80

2.64

1.5

3.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

399

1.54

2.63

2.3

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

169

1319

1.29

2.63

3.6

3.5

45.80

65.31

mg/l

0.65

151

1126

(44790048) Parainfluenza type 2 nucleic acid detection

521

1.47

2.63

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

521

1.47

2.63

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

521

1.47

2.63

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

521

1.47

2.63

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

129

970

1.34

2.62

1.4

1.3

3.54

3.73

mmol/l

1.43

120

913

(3045716) Anion gap in Serum or Plasma by calculation

424

1.52

2.61

4.3

3.0

11.27

10.54

mmol/l

1.15

418

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

159

1233

1.30

2.60

2.5

2.8

3.71

3.53

g/l

0.68

147

1178

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

128

963

1.34

2.59

1.5

773.10

1186.34

e6/l

0.27

106

758

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

264

3184

0.82

2.58

1.5

1.7

3.50

3.47

mmol/l

0.19

176

2169

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

111

818

1.37

2.57

1.6

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

7.15

2.55

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

7.15

2.55

1.0

1.1

1.54

1.50

mg/l

—

(4146454) Self-monitoring of blood glucose

387

1.53

2.53

3.0

2.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

426

3680

1.17

2.51

10.0

7.5

1.32

1.33

mmol/l

0.07

416

3607

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

181

1436

1.27

2.49

1.7

1.9

—

38.13

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

309

1.59

2.49

1.1

—

(3017704) Immunofixation for Urine

210

1.72

2.46

1.6

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.67

2.45

1.0

1.10

0.17

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

126

956

1.33

2.43

1.7

1.6

11062.40

13787.63

e6/l

0.34

665

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

344

1.55

2.40

1.2

1.1

48.70

41.65

mg/l

0.44

287

(3030467) Casts [#/volume] in Urine by Automated count

1208

11199

1.11

2.39

3.7

3.3

0.36

0.42

e6/l

0.66

905

8196

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

454

3960

1.16

2.38

3.7

4.2

25.80

22.84

ug/l

0.10

368

3218

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.12

2.38

1.4

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

167

1321

1.27

2.37

3.6

3.5

65.71

95.18

mg/l

0.27

149

1126

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

253

2098

1.22

2.36

1.1

14.06

1.38

u/ml

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.12

2.36

4.6

4.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

2.34

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.26

2.34

1.3

2.02

1.60

mmol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

217

1773

1.24

2.34

2.4

2.3

5688.95

5821.69

u/l

0.01

684

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

189

1521

1.25

2.33

1.5

1.6

12.79

16.19

u/ml

0.45

357

(1617658) Protocol used for examination of sentinel lymph nodes

288

0.45

2.28

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.46

2.27

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

707

1.37

2.27

2.0

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1608

1.24

2.26

2.3

3.51

3.73

g/l

1.66

180

1469

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

333

1.54

2.26

1.1

269.63

272.66

mg/l

0.03

289

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1609

1.24

2.25

2.3

7.21

7.42

g/l

1.17

180

1470

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1609

1.24

2.25

2.3

4.27

4.21

g/l

0.36

179

1471

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

106

1.99

2.25

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

239

1.64

2.25

2.6

220.72

154.38

e6/l

0.25

230

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

431

1.47

2.25

1.1

—

23.46

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

581

1.40

2.25

2.4

2.3

8.21

6.73

umol/l

0.44

432

(3013139) Helicobacter pylori Ag [Presence] in Stool

315

2681

1.19

2.24

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

342

1.53

2.24

1.5

1.4

9.23

8.58

mmol/l

0.56

329

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

2.18

1.8

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

112

852

1.32

2.16

1.7

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

305

1.55

2.16

2.2

1.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.29

2.15

6.7

5.2

—

(36304419) Bacteria [Presence] in Urine

1149

10685

1.10

2.12

3.6

3.2

10.17

0.28

estimate

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

437

1.45

2.11

2.3

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

714

6481

1.12

2.08

3.5

3.1

2.74

2.49

e6/l

0.33

379

3161

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

156

1247

1.26

2.07

3.4

0.33

0.35

iu/ml

0.29

688

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

124

1.86

2.06

2.1

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

1.80

2.04

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

132

1036

1.28

2.04

2.0

2.1

13.05

11.66

mg/l

0.39

122

966

(3032057) Clostridioides difficile [Presence] in Stool

2.18

2.04

2.5

2.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.00

2.04

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

105

1366

0.76

2.03

1.1

0.66

0.64

ratio

—

162

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

102

775

1.32

2.01

1.7

1.5

137.89

153.38

au/ml

0.33

218

(3002079) Sodium [Moles/time] in 24 hour Urine

185

1.68

2.00

1.2

1.4

165.23

163.62

mmol/24h

0.03

185

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

620

1.36

2.00

1.2

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

771

7046

1.11

1.99

3.3

3.0

1.27

1.16

e6/l

0.34

443

3740

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

975

9025

1.10

1.97

4.8

4.5

22.52

21.91

0.55

461

4382

(3000991) Gas panel - Venous blood

412

3626

1.15

1.95

11.8

8.6

—

(3038515) Glucose [Moles/volume] in Venous blood

105

805

1.31

1.95

4.2

3.2

8.08

7.47

mmol/l

1.20

105

777

(3008401) Mugwort IgE Ab [Units/volume] in Serum

106

814

1.31

1.94

1.1

1.04

1.29

u/ml

0.10

369

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

147

1178

1.26

1.93

3.4

3.3

6.59

2.80

ratio

0.56

103

682

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

522

1.39

1.92

1.8

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

227

1.59

1.90

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

548

4926

1.13

1.89

2.3

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

127

1004

1.27

1.88

1.5

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.31

1.87

1.0

0.01

0.05

u/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

637

1.34

1.86

1.1

5.40

5.77

u/ml

0.07

288

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

1511

1.22

1.85

2.1

2.3

2.72

2.93

g/l

2.51

165

1373

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

350

1.46

1.84

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.98

1.84

1.1

1.3

1.18

1.17

mmol/l

0.23

(21494814) CD8 cells/Lymphocytes in Specimen

152

1.71

1.83

2.1

29.31

30.30

0.14

152

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

152

1.71

1.83

1.0

14.42

14.63

u/ml

0.02

(3044290) Cell count panel - Cerebral spinal fluid

114

893

1.28

1.82

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

379

3334

1.15

1.82

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

175

1.66

1.82

3.9

4.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

615

1.34

1.79

2.4

2.0

—

12.60

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

295

1.50

1.79

1.5

24.90

24.12

u/ml

—

(3016228) CD19 cells/cells in Blood

153

1.70

1.79

2.1

8.88

8.33

0.06

146

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3302

32267

1.09

1.77

25.3

20.1

332.25

332.50

g/l

0.81

3280

32078

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

367

3230

1.15

1.76

2.2

—

(21494755) Public health laboratory ask at order entry panel

310

3553

0.86

1.75

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

836

7725

1.10

1.75

3.1

3.0

2.44

2.45

mmol/l

0.72

759

6930

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

202

1.59

1.70

1.3

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.88

1.70

1.1

1.2

45.84

39.37

g/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.29

1.70

1.0

0.23

0.86

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

144

1172

1.24

1.69

2.0

1.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

665

1.31

1.69

1.1

222.86

874.85

iu/ml

0.39

160

(44813793) Dust mix specific IgE antibody measurement

267

1.50

1.68

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

141

1.71

1.68

1.3

1.8

0.00

0.04

estimate

0.80

141

(3042111) Morphology [Interpretation] in Bone marrow Narrative

666

1.31

1.67

1.4

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.10

1.65

8.2

7.0

—

681.00

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

1476

1.21

1.65

1.5

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

151

1240

1.23

1.64

5.6

4.3

1.47

1.48

mg/l

0.07

144

1135

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

393

1.40

1.64

3.8

—

(3017509) Phencyclidine [Presence] in Urine

2.44

1.64

1.6

—

(3024928) Oxygen saturation in Venous blood

132

1069

1.24

1.63

3.3

3.0

65.11

62.04

0.82

123

1038

(3003888) Timothy IgE Ab [Units/volume] in Serum

107

846

1.27

1.62

1.1

4.41

5.58

u/ml

0.39

472

(3035947) Staphylolysin Ab [Units/volume] in Serum

174

1.61

1.60

1.1

—

5.00

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

412

1.39

1.60

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.91

1.59

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

2.11

1.55

1.8

2.3

3.36

3.08

ug/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

364

1.41

1.55

3.0

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

109

870

1.26

1.54

1.6

1.3

275.04

256.46

u/ml

0.26

512

(3001019) Free T4 and TSH panel - Serum or Plasma

160

1914

0.83

1.54

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

104

826

1.27

1.54

4.2

3.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.93

1.54

1.1

0.75

0.70

umol/24h

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.93

1.54

1.5

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

306

1.44

1.53

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

286

2502

1.15

1.53

3.1

3.5

4.36

4.51

pmol/l

1.79

254

2245

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

141

1160

1.22

1.53

2.6

196.13

189.94

0.31

133

1111

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

416

1.37

1.52

1.3

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.34

1.52

1.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

169

1417

1.20

1.51

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

1065

10012

1.08

1.51

4.9

4.2

90.27

89.37

0.56

1040

9796

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1390

1.20

1.51

2.3

10.01

10.24

g/l

0.30

146

1242

(3006442) Creatine [Moles/volume] in Serum or Plasma

250

1.48

1.49

1.4

1.5

86.38

82.76

umol/l

0.19

250

(3051611) Lipemic interference index of Serum or Plasma

367

1.39

1.49

4.2

3.4

13.69

12.40

index

0.30

213

(3016650) Hepatitis A virus Ab [Presence] in Serum

688

1.28

1.48

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

308

2716

1.14

1.48

2.1

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

128

1049

1.23

1.45

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.12

1.44

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

258

2253

1.15

1.43

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

100

799

1.26

1.43

1.1

1.13

1.80

u/ml

0.84

416

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

773

1.26

1.42

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

773

1.26

1.42

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

237

1.48

1.41

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

280

1.43

1.37

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

198

1.52

1.37

2.0

2.5

17.41

26.22

umol/l

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

272

1.44

1.37

1.3

12.26

11.64

u/l

0.14

247

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.61

1.36

3.3

3.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

106

858

1.24

1.36

1.5

127.05

182.14

pmol/l

0.66

101

837

(4035726) Immunohistochemistry procedure

373

3350

1.12

1.36

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

1.70

1.35

1.0

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

109

887

1.23

1.34

3.8

3.2

55.45

57.86

1.08

109

887

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

286

2529

1.14

1.34

4.9

4.0

23.96

24.17

mmol/l

0.50

280

2502

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.15

1.33

1.6

1.7

52.89

44.74

umol/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.15

1.33

1.0

1.1

2.46

1.73

umol/24h

—

(1616796) Gas panel - Central venous blood

111

906

1.23

1.33

4.7

3.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

745

1.25

1.32

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

692

1.26

1.31

1.1

3.73

3.40

u/ml

0.08

352

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

1.66

1.30

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.10

1.30

1.0

1.1

0.02

0.03

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

747

1.25

1.29

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.36

1.29

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

580

5350

1.10

1.29

2.4

2.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

336

1.37

1.27

1.2

1.3

2.00

2.14

mmol/l

0.28

310

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.05

1.26

1.0

1.3

—

mmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

373

3368

1.12

1.26

2.4

2.3

12.30

12.95

nmol/l

0.79

325

3059

(3005033) Fetal Nuchal fold Thickness US

913

0.79

1.25

1.5

1.22

1.26

0.38

646

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

228

1998

1.15

1.24

3.7

3.6

50.27

73.19

u/ml

0.81

215

1932

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

123

1.63

1.23

1.6

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

110

906

1.22

1.23

2.4

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

131

1.61

1.23

2.5

2.6

0.61

mmol/l

0.10

131

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

1.23

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.77

1.22

1.2

1.3

—

(40768446) Kidney Pathology biopsy report

155

1.55

1.22

2.4

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.63

1.21

2.2

3.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

700

1.25

1.21

1.2

21.68

37.67

u/l

1.02

600

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

279

3128

0.88

1.21

4.6

3.9

1.22

1.23

mmol/l

0.46

242

2705

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

110

1324

0.83

1.19

1.5

1.4

—

(3036489) Thrombin time

176

1519

1.17

1.18

2.2

21.29

21.00

0.25

157

1341

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

1.60

1.17

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

174

1.50

1.15

1.1

86.29

347.91

ng/l

—

(3025130) Human papilloma virus identified in Specimen

590

1.26

1.13

1.9

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

175

1.49

1.12

1.5

1.8

2.00

1.95

umol/l

0.08

160

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

493

1.28

1.12

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.90

1.12

1.9

1.7

25.18

40.85

pmol/l

0.48

(40768795) Lymph node Pathology biopsy report

379

1.32

1.12

1.3

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.38

1.09

3.2

7.7

100.20

101.38

g/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.08

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.69

1.07

1.1

7.95

9.07

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

1.87

1.07

1.1

1.3

66.18

68.63

ug/l

0.10

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.93

1.06

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

348

1.33

1.05

1.5

1.3

114895.93

98371.35

e6/l

0.07

238

(3040151) Glucose [Moles/volume] in Capillary blood

445

1.28

1.05

5.8

6.9

6.72

7.19

mmol/l

0.43

380

(3009466) Valproate [Moles/volume] in Serum or Plasma

570

1.25

1.04

5.0

5.5

384.75

359.78

umol/l

0.72

502

(3023410) Appearance of Cerebral spinal fluid

437

1.29

1.03

1.6

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.27

1.03

6.2

5.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

146

1.51

1.03

1.5

2.5

7.94

9.49

mg/l

0.65

127

(3002256) Pathology report gross observation

559

5208

1.08

1.02

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

554

1.25

1.02

1.1

1.60

1.50

g/l

1.12

502

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.89

1.01

1.0

—

(3003181) Sodium [Moles/volume] in Urine

746

1.21

0.99

1.5

1.4

60.59

63.14

mmol/l

0.25

606

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

100

1187

0.84

0.98

1.6

1.5

57.64

59.55

ug/l

0.14

988

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

158

0.57

0.98

2.2

3.0

1.28

1.21

ug/l

—

150

(3043238) Trisomy 21 risk [Likelihood] in Fetus

947

0.82

0.97

1.5

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

925

0.82

0.97

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.95

0.97

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

124

1.53

0.96

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.85

0.96

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

615

0.78

0.96

1.7

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

704

1.21

0.96

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1818

17632

1.05

0.94

12.9

11.3

0.00

e9/l

0.66

1477

14315

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.77

0.94

1.1

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

117

1.54

0.93

2.4

2.0

1.80

1.74

ratio

0.05

110

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.14

0.91

1.2

1.5

269.50

336.07

umol/24h

—

(3036603) Volume of Urine

287

1.33

0.91

1.7

1.5

2118.39

1959.17

0.47

282

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

1106

1.16

0.90

1.2

1.1

4.64

4.31

0.10

147

(3051387) C reactive protein [Mass/volume] in Capillary blood

802

1.19

0.89

4.9

3.3

28.49

26.97

mg/l

0.19

553

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

219

1.37

0.89

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

1.91

0.88

1.5

3.1

—

(40765096) Chromosome analysis panel by Banding

128

0.55

0.88

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

386

1.27

0.87

1.2

60.97

68.01

u/l

0.43

342

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.61

0.87

4.0

7.3

5.52

5.41

kpa

0.08

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

333

3059

1.10

0.87

3.1

2.7

66.64

66.99

ml/min/173m2

0.05

150

1298

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

334

1.29

0.86

1.2

101.35

109.19

pmol/l

0.59

334

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

582

0.79

0.86

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

101

861

1.18

0.86

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

128

1.49

0.85

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

187

1.39

0.85

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1.29

0.84

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

158

1395

1.14

0.84

2.5

2.3

0.70

0.86

g/l

0.30

135

1199

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.59

0.84

2.3

1.5

0.35

0.26

mmol/l

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

327

1.29

0.83

1.2

1.5

41.41

31.96

0.75

206

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

311

2856

1.10

0.83

1.2

104.37

137.77

u/ml

0.93

115

1042

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

202

0.64

0.82

1.1

1.2

10.38

8.75

mm/h

0.20

202

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

121

1.49

0.82

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

266

1.32

0.82

1.4

1.5

15.54

13.45

u/l

0.51

254

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

471

1.23

0.82

1.1

—

(4211845) Urine protein measurement

197

1.37

0.82

2.5

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

103

884

1.17

0.81

5.7

4.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

382

1.26

0.81

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

126

1439

0.87

0.80

1.8

1.7

6.22

4.51

mg/l

0.53

1046

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

190

1.37

0.78

2.1

2.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.56

0.78

1.3

—

(3006462) Nitrate [Presence] in Urine

174

1.38

0.76

2.7

3.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.77

0.76

5.0

5.2

3.98

2.49

mg/l

—

(40762365) Oxygen content in Arterial blood by calculation

1.70

0.75

1.9

2.6

15.73

14.84

ml/dl

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

124

1.45

0.75

1.0

1.2

93.14

88.06

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.57

0.74

3.5

2.9

21.77

415.99

ug/l

0.60

(3052851) Hemolysis interference index of Serum or Plasma

120

1052

1.14

0.74

3.8

3.3

3.58

2.04

index

0.81

544

(3000012) Reticulocyte production index

551

1.20

0.73

2.5

2.0

0.94

0.90

0.20

369

(3028679) Herpes simplex virus Ab [Presence] in Serum

245

1.31

0.73

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

132

0.61

0.73

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

406

1.23

0.73

1.5

1.3

1.47

1.51

nmol/l

0.08

371

(3035320) C reactive protein [Mass/volume] in Body fluid

299

1.27

0.72

2.7

33.58

30.23

mg/l

0.22

215

(3020874) Milk IgE Ab [Units/volume] in Serum

264

1.29

0.71

1.1

0.17

1.69

u/ml

1.21

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

229

1.31

0.71

1.3

1.1

1599.07

1480.88

miu/ml

0.22

229

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.92

0.70

2.4

4.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

318

1.26

0.70

1.1

—

(4198724) Urine methamphetamine measurement

212

1.32

0.70

2.5

2.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

608

0.82

0.69

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

169

1.36

0.69

1.5

1.6

0.47

0.50

e9/l

0.27

169

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

574

1.19

0.68

1.1

2.36

2.85

0.20

102

(3047189) Immunofixation for 24 hour Urine

178

1.35

0.68

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

483

1.20

0.68

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

144

1.39

0.67

1.9

1.5

445.65

325.00

nmol/24h

0.12

144

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

170

1.35

0.67

2.1

3.0

0.91

1.13

0.35

170

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

267

1.28

0.66

2.1

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

416

3912

1.07

0.65

2.8

2.5

38.29

38.27

u/l

0.00

363

3301

(21494434) Karyotype in Bone marrow

340

1.24

0.65

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

313

1.25

0.64

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

120

1.42

0.64

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

189

1.32

0.64

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

597

1.18

0.64

1.1

0.03

0.30

u/ml

3.72

204

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1.24

0.63

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

305

1.25

0.63

1.1

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

729

1.16

0.62

1.1

33.01

17.04

au/ml

0.65

178

(3008295) Osmolality of Serum or Plasma

488

1.19

0.62

1.3

1.5

280.24

279.34

mosm/kgh2o

0.11

364

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.63

0.62

1.4

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.60

0.61

1.3

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

200

1.30

0.60

1.1

1.3

68.17

73.96

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

122

1.39

0.60

2.9

2.1

4362.50

19924.75

e6/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

138

1243

1.11

0.59

1.4

1.3

—

(4195642) Thrombophilia screening test

565

1.17

0.59

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

372

1.21

0.59

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

603

1.16

0.58

1.2

6.13

3.69

u/ml

0.38

216

(3017569) Oxygen content in Arterial blood

228

1.27

0.58

1.9

2.0

15.01

16.46

1.15

228

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

318

1.23

0.58

2.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1096

0.88

0.58

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

106

1.42

0.57

1.1

1.3

204.52

377.48

ug/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.67

0.56

1.0

1.3

—

6.08

—

(3045142) Bone marrow Pathology biopsy report

457

1.18

0.56

1.4

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.46

0.56

14.5

13.5

4.88

5.89

mmol/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

513

1.17

0.55

1.7

1.6

309.08

345.62

mu/l

0.68

409

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.55

1.1

1.4

—

(3006270) Folate [Moles/volume] in Blood

302

1.23

0.55

1.3

1.1

377.04

383.55

nmol/l

0.05

265

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

157

1431

1.10

0.55

3.6

3.5

1098.23

3027.23

u/ml

0.46

136

1225

(3011288) Drugs identified in Urine by Screen method Nominal

151

1376

1.10

0.54

3.9

3.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.48

0.53

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

340

1.21

0.53

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

145

1320

1.10

0.53

1.6

1.5

9.95

9.09

u/l

0.35

118

1046

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

169

1.30

0.53

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

214

1.26

0.52

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.43

0.52

4.4

7.2

11.82

10.49

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

808

1.13

0.52

1.7

2.2

1.03

0.82

nmol/l

1.40

685

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

126

1.35

0.51

1.0

1.4

97.29

87.38

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.41

0.51

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

242

1.24

0.50

6.7

7.3

9.39

88.50

ug/l

0.61

159

(3015076) Soybean IgE Ab [Units/volume] in Serum

233

1.25

0.50

1.1

0.99

1.94

u/ml

0.28

(3024869) Neuronal Ab [Presence] in Serum

1.39

0.50

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

454

1.17

0.50

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

585

1.15

0.49

1.2

4.42

5.06

u/ml

0.16

270

(3023199) Leukocytes [#/volume] in Pleural fluid

473

1.16

0.49

1.5

1.4

2933.92

3576.86

e6/l

0.13

333

(3032868) Hemoglobin electrophoresis panel in Blood

1.56

0.49

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

280

1.22

0.48

1.5

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

128

1404

0.91

0.48

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

154

1.30

0.48

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

211

1965

1.08

0.48

2.7

2.2

—

(4268621) Lupus anticoagulant assay

428

1.17

0.48

2.1

2.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

299

1.21

0.47

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

598

1.14

0.46

1.2

—

(3000330) Specific gravity of Urine by Test strip

209

1949

1.08

0.46

4.3

3.5

1.02

ratio

1.48

185

1745

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.46

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

0.62

0.45

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

147

1.29

0.45

2.5

3.3

47.93

54.75

au/ml

—

(3018333) Ribosomal P Ab [Presence] in Serum

292

1.20

0.45

1.1

—

(44806071) Cardiolipin IgM antibody measurement

1.40

0.45

1.0

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

112

1.34

0.44

1.1

1.3

38.10

54.00

—

(3003694) ABO and Rh group [Type] in Blood

1146

11747

0.97

0.44

1.6

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.45

0.44

1.1

—

(3027008) Opiates [Presence] in Urine

211

1974

1.07

0.44

2.7

2.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

117

1068

1.10

0.43

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.24

0.43

1.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

184

1.25

0.43

1.6

1.9

134.09

153.64

0.49

176

(3023323) Follitropin [Units/volume] in Serum or Plasma

210

1966

1.07

0.43

1.4

25.57

23.87

iu/l

0.35

183

1647

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.61

0.43

8.8

1.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

528

1.14

0.42

1.9

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.52

0.41

1.0

1.2

12.60

20.73

u/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.04

—

(3028300) Cannabinoids [Presence] in Urine

211

1980

1.07

0.41

2.7

2.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

8.16

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.47

0.40

1.0

0.04

0.57

u/ml

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

555.59

—

(3016879) Cocaine [Presence] in Urine

196

1839

1.07

0.39

2.8

2.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

101

1105

0.91

0.39

1.5

0.92

0.95

ratio

0.32

653

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

101

1105

0.91

0.39

1.5

1.24

1.19

ratio

0.21

658

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

178

1.24

0.38

2.5

2.7

22.64

194.05

ug/l

0.68

163

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

101

1104

0.91

0.38

1.5

1.04

1.15

ratio

0.53

652

(3004716) Salmonella sp identified in Stool by Organism specific culture

213

2008

1.06

0.37

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

179

1.23

0.37

2.0

2.6

122.29

146.34

umol/l

—

107

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

234

1.20

0.37

2.2

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

107

1.31

0.37

1.2

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.36

2.6

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

583

1.12

0.35

1.1

—

(3024471) HLA-A [Type]

122

0.74

0.35

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

653

6721

0.97

0.34

3.2

0.91

0.78

ug/l

0.81

444

4374

(3021387) Prolactin [Units/volume] in Serum or Plasma

173

1628

1.07

0.33

1.7

338.50

290.19

mu/l

0.83

159

1483

(4094501) Cardiovascular stress test using bicycle ergometer

110

1018

1.08

0.33

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

596

1.11

0.33

1.4

2.37

3.90

ug/l

2.34

538

(3034092) Cytoplasmic Ig cells/cells in Blood

1.30

0.33

20.0

9.7

0.15

0.21

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

155

1.23

0.32

1.7

1.5

38.75

40.04

g/l

0.40

155

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

116

1080

1.08

0.31

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

400

0.87

0.30

1.6

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

277

1.16

0.30

1.6

3.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

249

1.17

0.30

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

629

6122

1.03

0.30

1.6

1.5

—

(40768441) Liver Pathology biopsy report

296

1.15

0.30

1.4

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

458

1.11

0.29

2.9

2.2

0.90

1.34

g/24h

0.97

273

(3029396) Erythrocyte agglutination [Presence] in Blood

110

0.73

0.28

6.4

3.0

—

(3044007) Cell count panel - Peritoneal fluid

121

1.24

0.28

3.3

2.1

—

(4034850) Laboratory test

125

1173

1.07

0.28

13.1

10.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

126

1184

1.07

0.27

2.3

0.01

0.02

g/l

0.86

115

1063

(3019832) Treponema pallidum Ab [Presence] in Serum

480

4661

1.03

0.27

1.8

—

(3024932) HLA-DR beta [Type]

120

0.75

0.27

1.3

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

499

1.10

0.27

2.3

2.1

31.98

32.43

0.26

494

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

122

1147

1.07

0.26

2.3

0.00

g/l

-0.00

108

1007

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

827

1.08

0.26

3.3

3.6

1332.78

731.49

u/ml

0.29

757

(21494890) Protein electrophoresis panel - 24 hour Urine

385

1.12

0.26

1.9

2.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

182

0.82

0.26

1.0

1.1

—

9.50

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

838

1.08

0.26

1.9

2.4

103.20

84.00

ug/min

0.21

514

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.68

0.26

1.0

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

235

1.15

0.25

2.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

204

1952

1.05

0.25

2.0

2.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.18

0.24

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

142

1.20

0.24

1.1

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

170

1.18

0.24

1.4

3.8

178.50

69.20

mg/l

—

120

(3014765) Yersinia sp identified in Stool by Organism specific culture

115

1084

1.06

0.24

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

116

1094

1.06

0.24

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.71

0.24

2.2

1.6

—

(40768806) Pleura Pathology biopsy report

401

0.90

0.23

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

237

1.14

0.23

1.7

1.5

4.89

7.03

u/l

1.50

207

(3038177) Helicobacter pylori Ab [Presence] in Serum

640

1.08

0.23

1.2

—

(4038314) Semen analysis, post vasectomy

1.28

0.23

1.4

1.2

—

(40761536) Microorganisms panel - Urine sediment

311

3211

0.97

0.22

4.7

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

401

3900

1.03

0.22

3.8

3.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

564

1.08

0.22

1.7

1.5

—

(3012501) Base excess in Blood by calculation

826

1.07

0.22

5.3

4.4

2.59

2.61

mmol/l

0.02

548

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

113

1070

1.06

0.21

2.3

0.00

g/l

-0.00

108

1006

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

23.67

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.3

—

210.86

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.37

—

(4133840) Spirometry

1.23

0.21

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

126

1.19

0.21

1.5

1.4

97.27

124.59

nmol/l

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.2

—

5.60

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3218

32020

1.02

0.20

24.2

19.4

13.71

13.58

6.15

3178

31589

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.25

0.20

1.3

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

112

0.80

0.20

1.3

1.5

11.08

25.51

—

104

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

302

0.89

0.19

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

821

1.06

0.19

1.4

1.5

62.19

59.92

ug/l

0.23

821

(3005011) Chlamydia sp Ab [Titer] in Serum

1.15

0.19

1.3

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

222

1.13

0.19

1.5

1.3

145.64

133.92

nmol/l

0.69

222

(3025577) Chromium [Mass/volume] in Blood

213

1.13

0.18

2.2

1.99

2.27

ug/l

0.28

183

(3051101) Glucose [Moles/volume] in Cord blood

1.21

0.18

5.9

5.8

7.90

8.44

mmol/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

252

1.11

0.17

1.1

0.37

4.18

u/ml

1.14

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

176

1.14

0.17

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

311

1.09

0.16

1.1

15.86

19.49

u/ml

0.31

133

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

145

1398

1.04

0.15

1.3

236.20

224.40

miu/ml

0.15

636

(3025018) Bordetella pertussis Ab [Titer] in Serum

293

1.09

0.15

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

245

1.10

0.15

2.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

140

1.14

0.15

2.9

2.4

840.50

790.68

e6/l

—

102

(40758292) HTLV I+II Ab panel - Serum

1.11

0.15

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

115

1105

1.04

0.14

2.1

14.20

8.80

iu/l

0.22

464

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.80

0.14

2.3

2.1

19.86

17.49

umol/l

—

(4281824) Cell count and differential, peritoneal fluid

399

0.93

0.14

1.3

1.2

—

(1002224) Polysomnography panel

178

1835

0.97

0.14

1.1

—

(3034426) Prothrombin time (PT)

118

0.85

0.14

1.2

27.20

28.67

—

118

(3044242) Glucose [Moles/volume] in Arterial blood

237

1.10

0.14

1.7

1.8

7.81

8.22

mmol/l

0.27

237

(3042733) HLA Ab [Presence] in Serum

122

1.15

0.13

5.8

4.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

108

1039

1.04

0.13

1.7

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

500

1.06

0.13

1.2

1.4

7.25

7.19

mmol/l

0.04

444

(3001893) Eosinophils/Leukocytes in Pleural fluid

117

0.85

0.13

1.5

1.6

0.62

2.56

—

100

(40768800) Prostate Pathology biopsy report

724

0.95

0.13

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

219

1.10

0.12

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

492

1.06

0.12

2.5

40.90

32.19

iu/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

763

0.96

0.12

3.4

0.82

nmol/l

0.06

615

(3045788) Cell count panel - Pleural fluid

385

1.07

0.12

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

208

2129

0.98

0.11

1.5

1.6

940.69

1003.81

mu/l

0.53

174

1790

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

201

1.09

0.11

2.7

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

201

1.09

0.11

2.7

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

270

0.93

0.10

1.1

1.4

149.29

203.28

pmol/l

0.68

270

(3013637) Mi-2 Ab [Presence] in Serum

125

1.12

0.10

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

125

1.12

0.10

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

125

1.12

0.10

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

125

1.12

0.10

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

187

0.91

0.10

2.1

2.2

0.88

1.84

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

951

0.97

0.10

1.9

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.06

0.09

1.8

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

389

1.05

0.09

5.2

5.4

21.18

67.33

u/ml

1.62

116

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.09

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.04

0.09

1.8

1.1

—

(3014891) Appearance of Pleural fluid

1.07

0.08

1.8

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

263

1.07

0.08

1.0

702.57

713.70

ng/l

0.05

177

(3024263) Appearance of Synovial fluid

185

1.08

0.08

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.06

0.08

1.6

2.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.04

0.08

1.3

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

264

1.06

0.07

1.0

314.67

318.45

ng/l

0.03

182

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

296

0.95

0.07

1.8

2.0

1.20

1.43

u/field

0.23

153

(21491868) Cryoglobulin [Mass/volume] in Serum

153

0.91

0.07

1.1

1.2

—

0.23

g/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

265

1.06

0.07

1.0

40.75

43.26

ng/l

0.16

179

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.02

0.07

1.2

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

549

0.96

0.06

1.1

2.24

2.45

eliau/ml

0.10

246

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.84

0.06

1.3

1.0

20.04

36.24

iu/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

414

1.04

0.06

1.5

1.4

23594.26

79227.48

e6/l

1.62

234

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

100

1.10

0.05

1.5

1.4

40.67

33.67

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

159

1568

1.01

0.05

3.1

2.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

130

1.08

0.04

3.1

2.8

36.00

29.65

umol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

685

0.98

0.04

1.5

0.26

0.40

nmol/l

2.23

536

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

230

1.04

0.03

2.4

1.9

117.33

112.93

ng/l

0.07

230

(3004775) Volume in Urine collected for unspecified duration

280

1.04

0.03

1.6

2.3

797.30

622.82

1.51

184

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

130

1285

1.01

0.03

2.0

1.9

40.40

40.27

nmol/l

0.02

121

1254

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

191

1.05

0.03

1.1

1.2

—

(40768793) Breast Pathology biopsy report

927

1.01

0.03

1.4

1.3

—

(3004451) EKG impression Narrative

231

1.04

0.02

1.2

1.3

—

(44806420) Estimation of glomerular filtration rate

410

1.02

0.02

2.4

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

928

1.01

0.02

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

309

0.97

0.02

1.1

2.97

9.72

iu/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

172

1.05

0.02

1.0

1.1

85.54

92.50

0.35

135

(3020961) Endomysium IgA Ab [Titer] in Serum

201

1999

1.01

0.01

1.1

15.13

135.09

titre

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

193

1.04

0.01

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

121

1219

0.99

0.01

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

283

1.02

0.01

1.9

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

116

0.95

0.00

1.8

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

604

1.01

0.00

3.2

4.1

41.83

31.73

u/ml

0.28

587

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.02

0.00

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

104

0.96

0.00

1.3

1.5

10.64

8.93

ug/l

—

104

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

174

0.98

0.00

1.2

1.1

168.44

189.43

iu/ml

0.15

174

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

254

0.98

0.00

24.0

19.0

1364.08

1438.46

nmol/l

0.19

245

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

974

1.00

0.00

2.1

1.9

196.07

208.19

pmol/l

0.52

921

(43055514) Macroprolactin [Presence] in Serum or Plasma

111

0.99

0.00

1.2

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.01

0.00

1.0

1.2

—

131.00

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.01

0.00

1.2

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

69.50

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

25.42

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.91

-0.00

1.2

1.4

—

0.78

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.00

-0.00

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.95

-0.00

1.0

1.3

0.09

6.54

u/ml

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

2.22

—

(3000285) Sodium [Moles/volume] in Blood

1.00

-0.00

1.3

1.2

138.00

138.69

mmol/l

—

(3033099) Centromere Ab [Titer] in Serum

0.91

-0.00

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.98

-0.00

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.91

-0.00

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.91

-0.00

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.01

-0.00

1.6

2.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3028.57

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.02

-0.00

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.98

-0.00

1.2

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PERFORATION and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_PERFORATION	1.099 [0.99, 1.22]	0.071
Birth year	0.996 [0.99, 1.0]	0.37

During the follow-up period (1.1.1998 — 31.12.2019), 1840 out of 14921 females with H8_PERFORATION died.

Males

Parameter	HR [95% CI]	p-value
H8_PERFORATION	1.182 [1.07, 1.31]	0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 2140 out of 16352 males with H8_PERFORATION died.

Mortality risk

Mortality risk for people of age

years, who have H8_PERFORATION.

N-year risk	Females	Males
1	0.103%	0.211%
5	0.734%	1.322%
10	1.628%	3.392%
15	2.984%	6.549%
20	5.382%	11.176%

Relationships between endpoints

↥

Index endpoint: H8_PERFORATION – Perforation of tympanic membrane

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Perforation of tympanic membrane

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints